| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 1.39e-08 | 8 | 243 | 5 | GO:0140945 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 6.14e-08 | 10 | 243 | 5 | GO:0140999 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 1.03e-07 | 20 | 243 | 6 | GO:0042800 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 9.47e-07 | 44 | 243 | 7 | GO:0140938 | |
| GeneOntologyMolecularFunction | G protein activity | 7.22e-06 | 59 | 243 | 7 | GO:0003925 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | HSP90B1 ABCC4 ABCA1 TDRD9 ABCA13 SMC1A MCM7 SEPTIN8 RAB9A HRAS TOR1B DNA2 RAB27A DYNC1H1 KRAS RAP1A RAP1B MRAS NRAS DDX60 TOR1A ARHGAP5 ABCE1 SEPTIN11 DNAH11 | 9.47e-06 | 775 | 243 | 25 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | HSP90B1 ABCC4 ABCA1 TDRD9 ABCA13 SMC1A APTX MCM7 SEPTIN8 RAB9A HRAS TOR1B DNA2 RAB27A DYNC1H1 KRAS RAP1A RAP1B MRAS NRAS DDX60 TOR1A ARHGAP5 ABCE1 SEPTIN11 DNAH11 | 1.26e-05 | 839 | 243 | 26 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | HSP90B1 ABCC4 ABCA1 TDRD9 ABCA13 SMC1A APTX MCM7 SEPTIN8 RAB9A HRAS TOR1B DNA2 RAB27A DYNC1H1 KRAS RAP1A RAP1B MRAS NRAS DDX60 TOR1A ARHGAP5 ABCE1 SEPTIN11 DNAH11 | 1.28e-05 | 840 | 243 | 26 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | HSP90B1 ABCC4 ABCA1 TDRD9 ABCA13 SMC1A APTX MCM7 SEPTIN8 RAB9A HRAS TOR1B DNA2 RAB27A DYNC1H1 KRAS RAP1A RAP1B MRAS NRAS DDX60 TOR1A ARHGAP5 ABCE1 SEPTIN11 DNAH11 | 1.28e-05 | 840 | 243 | 26 | GO:0016818 |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 1.87e-05 | 68 | 243 | 7 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 2.06e-05 | 69 | 243 | 7 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 2.49e-05 | 71 | 243 | 7 | GO:0042054 | |
| GeneOntologyMolecularFunction | GDP binding | 3.77e-05 | 103 | 243 | 8 | GO:0019003 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | CPPED1 CES5A PDE6B INPP5D NT5C3A AZGP1 APTX PFKFB2 PFKFB3 PGAM5 PTPN13 AGO3 PLCB1 DNA2 DNASE1L2 USB1 IARS1 GDPD3 PON2 PDE12 LPIN2 CDC25A CDC25B | 1.43e-04 | 807 | 243 | 23 | GO:0016788 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.59e-04 | 26 | 243 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 2.66e-04 | 103 | 243 | 7 | GO:0008276 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | CPPED1 PDE6B INPP5D NT5C3A APTX PFKFB2 PFKFB3 PGAM5 PTPN13 PLCB1 GDPD3 LPIN2 CDC25A CDC25B | 2.90e-04 | 386 | 243 | 14 | GO:0042578 |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 3.00e-04 | 105 | 243 | 7 | GO:0008170 | |
| GeneOntologyMolecularFunction | histone modifying activity | 5.20e-04 | 229 | 243 | 10 | GO:0140993 | |
| GeneOntologyMolecularFunction | phosphatase activity | CPPED1 INPP5D NT5C3A APTX PFKFB2 PFKFB3 PGAM5 PTPN13 LPIN2 CDC25A CDC25B | 8.20e-04 | 287 | 243 | 11 | GO:0016791 |
| GeneOntologyMolecularFunction | 6-phosphofructo-2-kinase activity | 8.71e-04 | 4 | 243 | 2 | GO:0003873 | |
| GeneOntologyMolecularFunction | GTPase activity | SEPTIN8 RAB9A HRAS RAB27A KRAS RAP1A RAP1B MRAS NRAS ARHGAP5 ABCE1 SEPTIN11 | 1.01e-03 | 341 | 243 | 12 | GO:0003924 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | HSP90B1 ABCC4 ABCA1 TDRD9 ABCA13 SMC1A MCM7 TOR1B DNA2 DYNC1H1 DDX60 TOR1A ABCE1 DNAH11 | 1.07e-03 | 441 | 243 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | general transcription initiation factor binding | 1.09e-03 | 64 | 243 | 5 | GO:0140296 | |
| GeneOntologyMolecularFunction | fructose-2,6-bisphosphate 2-phosphatase activity | 1.44e-03 | 5 | 243 | 2 | GO:0004331 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 2.49e-06 | 75 | 242 | 8 | GO:0035097 | |
| GeneOntologyCellularComponent | transferase complex | SETD1A DCAF6 TBKBP1 SETD1B KMT2B KLHL41 PHKA1 PIK3C2B PIK3CB ANKIB1 CCNA1 KMT2A DNA2 TBP ATG5 NAA15 RB1 NSD1 VIRMA CCNA2 TGFBR2 KMT2D GTF2H2 RNF2 POLR1E CCNE2 PRIM2 PAXIP1 FBXO21 | 2.54e-06 | 963 | 242 | 29 | GO:1990234 |
| GeneOntologyCellularComponent | methyltransferase complex | 4.65e-06 | 108 | 242 | 9 | GO:0034708 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | TBKBP1 PHKA1 PIK3C2B PIK3CB CCNA1 DNA2 TBP RB1 CCNA2 TGFBR2 GTF2H2 POLR1E CCNE2 PRIM2 | 3.90e-05 | 335 | 242 | 14 | GO:0061695 |
| GeneOntologyCellularComponent | secretory vesicle | ABCC4 CPPED1 ABCA13 ACLY CHRNB4 SEMA4C SEPTIN8 MAGED2 CT55 SYN1 SYN2 TRAPPC4 PYGL C3 MME DMD RAB27A DYNC1H1 VEGFA RAP1A RAP1B NRAS ATG7 ZPBP TOR1A ECE1 CSH1 CSH2 OSTF1 GABBR1 | 1.18e-04 | 1246 | 242 | 30 | GO:0099503 |
| GeneOntologyCellularComponent | glutamatergic synapse | DAB1 MPDZ MDGA2 SEMA4C SCN8A SCN10A HRAS PLCB1 SYN2 NR3C2 ATG5 RAP1A RAP1B DOCK10 ARFGEF2 NBEA RPSA NR3C1 TIAM1 VPS35 SEPTIN11 GABBR1 | 2.21e-04 | 817 | 242 | 22 | GO:0098978 |
| GeneOntologyCellularComponent | cyclin A2-CDK2 complex | 3.97e-04 | 3 | 242 | 2 | GO:0097124 | |
| GeneOntologyCellularComponent | somatodendritic compartment | DAB1 MPDZ UPF3B RTN1 STAT1 SACS SCN8A SYN1 TRAPPC4 KCNQ3 KDR MME DMD RAB27A DYNC1H1 PMM2 ANK3 DOCK10 ARFGEF2 RPSA NR3C1 CASK TIAM1 VPS35 SEPTIN11 GIGYF2 ATF4 GABBR1 | 4.83e-04 | 1228 | 242 | 28 | GO:0036477 |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 5.00e-04 | 157 | 242 | 8 | GO:1902554 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 6.66e-04 | 164 | 242 | 8 | GO:0098982 | |
| GeneOntologyCellularComponent | secretory granule | ABCC4 CPPED1 ABCA13 ACLY CHRNB4 MAGED2 CT55 PYGL C3 MME DMD RAB27A DYNC1H1 VEGFA RAP1A RAP1B NRAS ATG7 ZPBP TOR1A ECE1 CSH1 CSH2 OSTF1 | 7.41e-04 | 1014 | 242 | 24 | GO:0030141 |
| GeneOntologyCellularComponent | septin cytoskeleton | 7.68e-04 | 16 | 242 | 3 | GO:0032156 | |
| GeneOntologyCellularComponent | cilium | CEP104 ABCC4 PDE6B MYO7A TTC21A ADGRV1 KCNU1 CT55 TTLL1 RAB27A ATG5 RAP1A ATG7 ARFGEF2 DNAI3 CASK TIAM1 CFAP20 NEK8 IFT122 CATSPERG DNAH11 | 7.91e-04 | 898 | 242 | 22 | GO:0005929 |
| GeneOntologyCellularComponent | postsynaptic specialization | MPDZ RTN1 CHRNB4 SEMA4C SCN8A SYN1 SYN2 TRAPPC4 NR3C2 DMD ANK3 NR3C1 TIAM1 VPS35 SEPTIN11 | 8.16e-04 | 503 | 242 | 15 | GO:0099572 |
| GeneOntologyCellularComponent | protein kinase complex | 8.43e-04 | 170 | 242 | 8 | GO:1902911 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 9.24e-04 | 17 | 242 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | MPDZ RTN1 SEMA4C SCN8A SYN1 SYN2 TRAPPC4 NR3C2 DMD ANK3 ARFGEF2 NR3C1 TIAM1 VPS35 SEPTIN11 | 1.20e-03 | 523 | 242 | 15 | GO:0098984 |
| GeneOntologyCellularComponent | asymmetric synapse | MPDZ RTN1 SEMA4C SCN8A SYN1 SYN2 TRAPPC4 NR3C2 DMD ANK3 ARFGEF2 NR3C1 TIAM1 VPS35 | 1.41e-03 | 477 | 242 | 14 | GO:0032279 |
| GeneOntologyCellularComponent | euchromatin | 1.49e-03 | 72 | 242 | 5 | GO:0000791 | |
| GeneOntologyCellularComponent | node of Ranvier | 1.51e-03 | 20 | 242 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | Weibel-Palade body | 1.94e-03 | 6 | 242 | 2 | GO:0033093 | |
| GeneOntologyCellularComponent | growth hormone receptor complex | 1.94e-03 | 6 | 242 | 2 | GO:0070195 | |
| GeneOntologyCellularComponent | costamere | 2.01e-03 | 22 | 242 | 3 | GO:0043034 | |
| HumanPheno | Linear nevus sebaceous | 1.01e-05 | 3 | 111 | 3 | HP:0010817 | |
| Domain | Post-SET_dom | 5.34e-10 | 16 | 239 | 7 | IPR003616 | |
| Domain | PostSET | 5.34e-10 | 16 | 239 | 7 | SM00508 | |
| Domain | POST_SET | 5.34e-10 | 16 | 239 | 7 | PS50868 | |
| Domain | - | ABCC4 ABCA1 TDRD9 MYO7A ABCA13 SMC1A MCM7 PFKFB2 PFKFB3 SEPTIN8 RAB9A HRAS TOR1B DNA2 RAB27A DYNC1H1 KRAS RAP1A RAP1B MRAS NRAS DDX60 TOR1A CASK ARHGAP5 ABCE1 SEPTIN11 DNAH11 | 3.57e-07 | 746 | 239 | 28 | 3.40.50.300 |
| Domain | SET | 7.99e-07 | 41 | 239 | 7 | PF00856 | |
| Domain | P-loop_NTPase | ABCC4 ABCA1 TDRD9 MYO7A ABCA13 SMC1A MCM7 PFKFB2 PFKFB3 SEPTIN8 RAB9A HRAS TOR1B DNA2 RAB27A DYNC1H1 KRAS RAP1A RAP1B MRAS NRAS GAL3ST1 DDX60 TOR1A CASK ARHGAP5 ABCE1 SEPTIN11 DNAH11 | 1.45e-06 | 848 | 239 | 29 | IPR027417 |
| Domain | SET | 1.80e-06 | 46 | 239 | 7 | SM00317 | |
| Domain | SET_dom | 3.22e-06 | 50 | 239 | 7 | IPR001214 | |
| Domain | SET | 3.22e-06 | 50 | 239 | 7 | PS50280 | |
| Domain | RAS | 4.91e-06 | 35 | 239 | 6 | PS51421 | |
| Domain | Small_GTPase_Ras | 6.88e-06 | 37 | 239 | 6 | IPR020849 | |
| Domain | Ion_trans_dom | 1.60e-05 | 114 | 239 | 9 | IPR005821 | |
| Domain | Ion_trans | 1.60e-05 | 114 | 239 | 9 | PF00520 | |
| Domain | FYRC | 2.03e-05 | 5 | 239 | 3 | SM00542 | |
| Domain | FYRN | 2.03e-05 | 5 | 239 | 3 | SM00541 | |
| Domain | K_chnl_volt-dep_KCNQ_C | 2.03e-05 | 5 | 239 | 3 | IPR013821 | |
| Domain | K_chnl_volt-dep_KCNQ | 2.03e-05 | 5 | 239 | 3 | IPR003937 | |
| Domain | FYRN | 2.03e-05 | 5 | 239 | 3 | PF05964 | |
| Domain | FYRC | 2.03e-05 | 5 | 239 | 3 | PF05965 | |
| Domain | FYrich_C | 2.03e-05 | 5 | 239 | 3 | IPR003889 | |
| Domain | FYrich_N | 2.03e-05 | 5 | 239 | 3 | IPR003888 | |
| Domain | FYRC | 2.03e-05 | 5 | 239 | 3 | PS51543 | |
| Domain | FYRN | 2.03e-05 | 5 | 239 | 3 | PS51542 | |
| Domain | KCNQ_channel | 2.03e-05 | 5 | 239 | 3 | PF03520 | |
| Domain | Ras | 6.47e-05 | 136 | 239 | 9 | PF00071 | |
| Domain | N-SET | 1.63e-04 | 2 | 239 | 2 | PF11764 | |
| Domain | MeTrfase_trithorax | 1.63e-04 | 2 | 239 | 2 | IPR016569 | |
| Domain | TBP_eukaryotic | 1.63e-04 | 2 | 239 | 2 | IPR033710 | |
| Domain | Dystrophin | 1.63e-04 | 2 | 239 | 2 | IPR016344 | |
| Domain | N-SET | 1.63e-04 | 2 | 239 | 2 | SM01291 | |
| Domain | Cyclin_A2_chordates | 1.63e-04 | 2 | 239 | 2 | IPR015453 | |
| Domain | COMPASS_Set1_N-SET | 1.63e-04 | 2 | 239 | 2 | IPR024657 | |
| Domain | TBP_CS | 1.63e-04 | 2 | 239 | 2 | IPR030491 | |
| Domain | Calx_beta | 1.64e-04 | 9 | 239 | 3 | IPR003644 | |
| Domain | Calx-beta | 1.64e-04 | 9 | 239 | 3 | PF03160 | |
| Domain | Small_GTPase | 2.23e-04 | 160 | 239 | 9 | IPR001806 | |
| Domain | PGAM | 2.32e-04 | 10 | 239 | 3 | SM00855 | |
| Domain | PG_MUTASE | 2.32e-04 | 10 | 239 | 3 | PS00175 | |
| Domain | Na_channel_asu | 2.32e-04 | 10 | 239 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 2.32e-04 | 10 | 239 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 2.32e-04 | 10 | 239 | 3 | PF06512 | |
| Domain | PHD | 3.97e-04 | 75 | 239 | 6 | PF00628 | |
| Domain | His_Pase_superF_clade-1 | 4.18e-04 | 12 | 239 | 3 | IPR013078 | |
| Domain | His_Phos_1 | 4.18e-04 | 12 | 239 | 3 | PF00300 | |
| Domain | TFIID | 4.85e-04 | 3 | 239 | 2 | PS00351 | |
| Domain | Torsin_1/2 | 4.85e-04 | 3 | 239 | 2 | IPR017378 | |
| Domain | GYF | 4.85e-04 | 3 | 239 | 2 | SM00444 | |
| Domain | TBP | 4.85e-04 | 3 | 239 | 2 | PF00352 | |
| Domain | Synapsin_N | 4.85e-04 | 3 | 239 | 2 | PF10581 | |
| Domain | Synapsin | 4.85e-04 | 3 | 239 | 2 | PF02078 | |
| Domain | - | 4.85e-04 | 3 | 239 | 2 | 3.30.1490.40 | |
| Domain | Synapsin | 4.85e-04 | 3 | 239 | 2 | IPR001359 | |
| Domain | GYF | 4.85e-04 | 3 | 239 | 2 | PS50829 | |
| Domain | MPI_Phosphatase | 4.85e-04 | 3 | 239 | 2 | IPR000751 | |
| Domain | Synapsin_pre-ATP-grasp_dom | 4.85e-04 | 3 | 239 | 2 | IPR020897 | |
| Domain | Synapsin_ATP-bd_dom | 4.85e-04 | 3 | 239 | 2 | IPR020898 | |
| Domain | TBP | 4.85e-04 | 3 | 239 | 2 | IPR000814 | |
| Domain | SYNAPSIN_1 | 4.85e-04 | 3 | 239 | 2 | PS00415 | |
| Domain | SYNAPSIN_2 | 4.85e-04 | 3 | 239 | 2 | PS00416 | |
| Domain | Synapsin_C | 4.85e-04 | 3 | 239 | 2 | PF02750 | |
| Domain | M-inducer_phosp | 4.85e-04 | 3 | 239 | 2 | PF06617 | |
| Domain | Synapsin_CS | 4.85e-04 | 3 | 239 | 2 | IPR019735 | |
| Domain | Synapsin_P_site | 4.85e-04 | 3 | 239 | 2 | IPR019736 | |
| Domain | GYF | 4.85e-04 | 3 | 239 | 2 | PF02213 | |
| Domain | Znf_PHD-finger | 5.26e-04 | 79 | 239 | 6 | IPR019787 | |
| Domain | AAA+_ATPase | 5.40e-04 | 144 | 239 | 8 | IPR003593 | |
| Domain | AAA | 5.40e-04 | 144 | 239 | 8 | SM00382 | |
| Domain | ATP_grasp_subdomain_2 | 6.27e-04 | 31 | 239 | 4 | IPR013816 | |
| Domain | 6Phosfructo_kin | 9.62e-04 | 4 | 239 | 2 | IPR013079 | |
| Domain | 6Pfruct_kin | 9.62e-04 | 4 | 239 | 2 | IPR003094 | |
| Domain | GYF | 9.62e-04 | 4 | 239 | 2 | IPR003169 | |
| Domain | 6PF2K | 9.62e-04 | 4 | 239 | 2 | PF01591 | |
| Domain | PHD | 9.89e-04 | 89 | 239 | 6 | SM00249 | |
| Domain | Znf_PHD | 1.11e-03 | 91 | 239 | 6 | IPR001965 | |
| Domain | Cyclin_C | 1.23e-03 | 17 | 239 | 3 | PF02984 | |
| Domain | Cyclin_C | 1.23e-03 | 17 | 239 | 3 | SM01332 | |
| Domain | Cyclin_C-dom | 1.23e-03 | 17 | 239 | 3 | IPR004367 | |
| Domain | CYCLIN | 1.37e-03 | 38 | 239 | 4 | SM00385 | |
| Domain | ZF_PHD_2 | 1.39e-03 | 95 | 239 | 6 | PS50016 | |
| Domain | Small_GTP-bd_dom | 1.42e-03 | 167 | 239 | 8 | IPR005225 | |
| Domain | - | 1.46e-03 | 18 | 239 | 3 | 3.30.470.20 | |
| Domain | ZF_PHD_1 | 1.46e-03 | 96 | 239 | 6 | PS01359 | |
| Domain | AWS | 1.59e-03 | 5 | 239 | 2 | SM00570 | |
| Domain | Torsin | 1.59e-03 | 5 | 239 | 2 | PF06309 | |
| Domain | AWS | 1.59e-03 | 5 | 239 | 2 | PS51215 | |
| Domain | AWS_dom | 1.59e-03 | 5 | 239 | 2 | IPR006560 | |
| Domain | Torsin | 1.59e-03 | 5 | 239 | 2 | IPR010448 | |
| Domain | - | 1.66e-03 | 40 | 239 | 4 | 1.10.472.10 | |
| Domain | RNaseH-like_dom | 1.90e-03 | 69 | 239 | 5 | IPR012337 | |
| Domain | - | 2.01e-03 | 20 | 239 | 3 | 3.30.565.10 | |
| Domain | - | 2.01e-03 | 20 | 239 | 3 | 3.40.50.1240 | |
| Domain | His_PPase_superfam | 2.01e-03 | 20 | 239 | 3 | IPR029033 | |
| Domain | Cyclin-like | 2.18e-03 | 43 | 239 | 4 | IPR013763 | |
| Domain | HATPase_C | 2.32e-03 | 21 | 239 | 3 | IPR003594 | |
| Domain | SOMATOTROPIN_2 | 2.36e-03 | 6 | 239 | 2 | PS00338 | |
| Domain | SOMATOTROPIN_1 | 2.36e-03 | 6 | 239 | 2 | PS00266 | |
| Domain | Na_trans_cytopl | 2.36e-03 | 6 | 239 | 2 | IPR024583 | |
| Domain | EF-hand_dom_typ1 | 2.36e-03 | 6 | 239 | 2 | IPR015153 | |
| Domain | EF-hand_dom_typ2 | 2.36e-03 | 6 | 239 | 2 | IPR015154 | |
| Domain | EF-hand_2 | 2.36e-03 | 6 | 239 | 2 | PF09068 | |
| Pathway | REACTOME_SIGNALING_BY_PDGFR_IN_DISEASE | 5.79e-09 | 20 | 195 | 7 | M29849 | |
| Pathway | REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS | 3.52e-07 | 12 | 195 | 5 | M29851 | |
| Pathway | WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER | 2.88e-06 | 110 | 195 | 10 | M48043 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 2.95e-06 | 46 | 195 | 7 | MM14933 | |
| Pathway | WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS | 3.56e-06 | 18 | 195 | 5 | M39737 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P27_CELL_CYCLE_G1_S_N00482 | 4.24e-06 | 9 | 195 | 4 | M47578 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 4.78e-06 | 19 | 195 | 5 | M27423 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P27_CELL_CYCLE_G1_S_N00264 | 1.09e-05 | 11 | 195 | 4 | M47492 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 1.24e-05 | 38 | 195 | 6 | MM17073 | |
| Pathway | PID_EPHB_FWD_PATHWAY | 1.68e-05 | 40 | 195 | 6 | M62 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 2.25e-05 | 42 | 195 | 6 | M48018 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 2.30e-05 | 13 | 195 | 4 | MM15171 | |
| Pathway | REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS | 2.55e-05 | 5 | 195 | 3 | M26921 | |
| Pathway | WP_HISTONE_MODIFICATIONS | 3.07e-05 | 65 | 195 | 7 | M39374 | |
| Pathway | KEGG_PROSTATE_CANCER | 3.15e-05 | 89 | 195 | 8 | M13191 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 3.19e-05 | 14 | 195 | 4 | M47390 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P27_CELL_CYCLE_G1_S | 3.19e-05 | 14 | 195 | 4 | M47427 | |
| Pathway | WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING | 3.40e-05 | 66 | 195 | 7 | M39684 | |
| Pathway | REACTOME_S_PHASE | 3.53e-05 | 146 | 195 | 10 | MM15378 | |
| Pathway | WP_CELL_CYCLE | 4.30e-05 | 120 | 195 | 9 | M39650 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 4.30e-05 | 15 | 195 | 4 | M47389 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 4.30e-05 | 15 | 195 | 4 | M47475 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | 4.36e-05 | 29 | 195 | 5 | M779 | |
| Pathway | KEGG_RENAL_CELL_CARCINOMA | 4.99e-05 | 70 | 195 | 7 | M13266 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 4.99e-05 | 70 | 195 | 7 | M3115 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 4.99e-05 | 70 | 195 | 7 | M27231 | |
| Pathway | REACTOME_ESTROGEN_STIMULATED_SIGNALING_THROUGH_PRKCZ | 5.06e-05 | 6 | 195 | 3 | M27951 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_RASSF1_TO_RAS_RASSF1_SIGNALING_PATHWAY | 5.06e-05 | 6 | 195 | 3 | M47433 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RAS_UBIQUITINATION_BY_CUL3_COMPLEX | 5.06e-05 | 6 | 195 | 3 | M47931 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_SPRED_AND_NF1 | 5.06e-05 | 6 | 195 | 3 | M47932 | |
| Pathway | KEGG_CELL_CYCLE | 5.92e-05 | 125 | 195 | 9 | M7963 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 6.10e-05 | 31 | 195 | 5 | M877 | |
| Pathway | WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA | 7.16e-05 | 74 | 195 | 7 | M39857 | |
| Pathway | REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS | 8.76e-05 | 7 | 195 | 3 | M29717 | |
| Pathway | REACTOME_SOS_MEDIATED_SIGNALLING | 8.76e-05 | 7 | 195 | 3 | M19489 | |
| Pathway | REACTOME_S_PHASE | 8.98e-05 | 163 | 195 | 10 | M3158 | |
| Pathway | REACTOME_TIE2_SIGNALING | 9.33e-05 | 18 | 195 | 4 | M11932 | |
| Pathway | PID_MAPK_TRK_PATHWAY | 9.66e-05 | 34 | 195 | 5 | M270 | |
| Pathway | PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY | 1.11e-04 | 35 | 195 | 5 | M127 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_RAS_ERK_SIGNALING_PATHWAY | 1.17e-04 | 19 | 195 | 4 | M47793 | |
| Pathway | PID_SHP2_PATHWAY | 1.31e-04 | 57 | 195 | 6 | M100 | |
| Pathway | REACTOME_ONCOGENIC_MAPK_SIGNALING | 1.38e-04 | 82 | 195 | 7 | M27626 | |
| Pathway | REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS | 1.39e-04 | 8 | 195 | 3 | M27919 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RASGAP | 1.39e-04 | 8 | 195 | 3 | M47935 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.44e-04 | 58 | 195 | 6 | M2049 | |
| Pathway | REACTOME_SIGNALING_BY_KIT_IN_DISEASE | 1.45e-04 | 20 | 195 | 4 | M39002 | |
| Pathway | WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA | 1.59e-04 | 59 | 195 | 6 | M39750 | |
| Pathway | WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE | 1.60e-04 | 84 | 195 | 7 | M39839 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACH_CHRN_RAS_ERK_SIGNALING_PATHWAY | 1.77e-04 | 21 | 195 | 4 | M47792 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | HSP90B1 PFKFB2 PFKFB3 PIK3C2B PIK3CB HRAS KDR VEGFA KRAS NRAS EFNA5 CSH1 CSH2 ATF4 | 1.79e-04 | 326 | 195 | 14 | MM15917 |
| Pathway | WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY | 1.89e-04 | 39 | 195 | 5 | M39905 | |
| Pathway | WP_G1_TO_S_CELL_CYCLE_CONTROL | 1.91e-04 | 61 | 195 | 6 | MM15912 | |
| Pathway | PID_TRKR_PATHWAY | 1.91e-04 | 61 | 195 | 6 | M187 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_PI3K_SIGNALING_PATHWAY | 2.06e-04 | 9 | 195 | 3 | M47391 | |
| Pathway | REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN | 2.06e-04 | 9 | 195 | 3 | M27156 | |
| Pathway | REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R | 2.06e-04 | 9 | 195 | 3 | M27173 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G1_CELL_CYCLE_ARREST | 2.06e-04 | 9 | 195 | 3 | MM15337 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS | 2.06e-04 | 9 | 195 | 3 | M27904 | |
| Pathway | REACTOME_MAP2K_AND_MAPK_ACTIVATION | 2.14e-04 | 40 | 195 | 5 | M27557 | |
| Pathway | WP_BLADDER_CANCER | 2.14e-04 | 40 | 195 | 5 | M39523 | |
| Pathway | WP_PANCREATIC_ADENOCARCINOMA_PATHWAY | 2.30e-04 | 89 | 195 | 7 | M39732 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_PI3K_SIGNALING_PATHWAY | 2.30e-04 | 89 | 195 | 7 | M47963 | |
| Pathway | WP_RETINOBLASTOMA_GENE_IN_CANCER | 2.47e-04 | 90 | 195 | 7 | M39678 | |
| Pathway | WP_G1_TO_S_CELL_CYCLE_CONTROL | 2.50e-04 | 64 | 195 | 6 | M39627 | |
| Pathway | KEGG_MEDICUS_REFERENCE_E2_ER_RAS_ERK_SIGNALING_PATHWAY | 2.56e-04 | 23 | 195 | 4 | M47799 | |
| Pathway | KEGG_BLADDER_CANCER | 2.70e-04 | 42 | 195 | 5 | M19096 | |
| Pathway | REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS | 2.72e-04 | 65 | 195 | 6 | M38994 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | HSP90B1 PFKFB2 PFKFB3 PIK3C2B PIK3CB HRAS KDR VEGFA KRAS NRAS EFNA5 CSH1 ATF4 | 2.99e-04 | 302 | 195 | 13 | M39719 |
| Pathway | KEGG_MEDICUS_REFERENCE_DNA_REPLICATION_LICENSING | 3.04e-04 | 24 | 195 | 4 | M47857 | |
| Pathway | KEGG_LYSINE_DEGRADATION | 3.37e-04 | 44 | 195 | 5 | M13720 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 3.37e-04 | 44 | 195 | 5 | MM15527 | |
| Pathway | WP_ACUTE_MYELOID_LEUKEMIA | 3.48e-04 | 68 | 195 | 6 | M48322 | |
| Pathway | WP_MELANOMA | 3.48e-04 | 68 | 195 | 6 | M39811 | |
| Pathway | WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR | 3.58e-04 | 25 | 195 | 4 | M39794 | |
| Pathway | WP_NOVEL_JUNDMP1_PATHWAY | 3.58e-04 | 25 | 195 | 4 | MM15984 | |
| Pathway | REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | 3.58e-04 | 25 | 195 | 4 | M808 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK2_TRKB | 3.58e-04 | 25 | 195 | 4 | M27864 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 3.58e-04 | 25 | 195 | 4 | M27865 | |
| Pathway | REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | 3.58e-04 | 25 | 195 | 4 | MM15379 | |
| Pathway | REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS | 3.75e-04 | 45 | 195 | 5 | M27623 | |
| Pathway | WP_MAPK_SIGNALING_PATHWAY | 3.85e-04 | 160 | 195 | 9 | MM15990 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE | 3.96e-04 | 11 | 195 | 3 | M27535 | |
| Pathway | KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 3.96e-04 | 11 | 195 | 3 | M47370 | |
| Pathway | KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 3.96e-04 | 11 | 195 | 3 | M47371 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3 | 3.96e-04 | 11 | 195 | 3 | M27911 | |
| Pathway | REACTOME_MET_ACTIVATES_RAS_SIGNALING | 3.96e-04 | 11 | 195 | 3 | M27740 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2 | 3.96e-04 | 11 | 195 | 3 | M29814 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY | 3.96e-04 | 11 | 195 | 3 | M47436 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY | 3.96e-04 | 11 | 195 | 3 | M47432 | |
| Pathway | KEGG_PANCREATIC_CANCER | 4.08e-04 | 70 | 195 | 6 | M9726 | |
| Pathway | REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY | 4.08e-04 | 70 | 195 | 6 | MM15389 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586 | 4.16e-04 | 46 | 195 | 5 | M39661 | |
| Pathway | WP_CHEMOKINE_SIGNALING | 4.83e-04 | 165 | 195 | 9 | M39400 | |
| Pathway | REACTOME_G0_AND_EARLY_G1 | 4.86e-04 | 27 | 195 | 4 | M532 | |
| Pathway | WP_INTEGRATED_CANCER_PATHWAY | 5.08e-04 | 48 | 195 | 5 | M39628 | |
| Pathway | PID_PI3KCI_PATHWAY | 5.08e-04 | 48 | 195 | 5 | M141 | |
| Pathway | KEGG_CHRONIC_MYELOID_LEUKEMIA | 5.12e-04 | 73 | 195 | 6 | M321 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 5.23e-04 | 12 | 195 | 3 | M47369 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY | 5.23e-04 | 12 | 195 | 3 | M47815 | |
| Pathway | BIOCARTA_RB_PATHWAY | 5.23e-04 | 12 | 195 | 3 | MM1466 | |
| Pubmed | Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases. | 3.03e-12 | 8 | 243 | 6 | 23130995 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ABCC4 DCAF6 KCNH8 TBKBP1 TTC21A ASH1L DAB1 ADGRV1 TTF1 PTPN13 KCNQ5 SUPT6H NECTIN2 SEL1L3 ANKIB1 MME UTRN GOLGA4 NSMAF RAP1A ANK3 ATG7 RBM4 FRMPD1 PON2 CHST11 CASK GTF2H2 EFNA5 PCNX4 NAT10 SEPTIN11 OSTF1 IFT122 MAPK6 CATSPERG FBXO21 | 2.19e-11 | 1489 | 243 | 37 | 28611215 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SETD1A HSP90B1 SETD1B ACLY SMC1A AZGP1 MCM7 PGAM5 STAT1 MAGED2 SGPL1 FDPS ANKIB1 PYGL UTRN DYNC1H1 GOLGA4 PMM2 ATG5 USP36 NAA15 RB1 MBOAT7 IARS1 DOCK10 RPSA PRPF8 ACTR1A TGM3 PDE12 POLR1E ABCE1 PRIM2 VPS35 NAT10 | 2.73e-11 | 1353 | 243 | 35 | 29467282 |
| Pubmed | 6.68e-11 | 50 | 243 | 9 | 37974198 | ||
| Pubmed | 8.80e-10 | 8 | 243 | 5 | 22266653 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | TBKBP1 MYO7A SMC1A TTC21A MCM7 GIGYF1 PFKFB2 PTPN13 MAGED2 SCD NECTIN2 TRAPPC4 PYGL C3 DYNC1H1 ANK3 RB1 MBOAT7 IARS1 PRPF8 ACTR1A RNF2 TIAM1 CFAP20 NEK8 SEC23IP SEPTIN11 GIGYF2 IFT122 CDC25B EDRF1 DCTN3 | 1.07e-09 | 1321 | 243 | 32 | 27173435 |
| Pubmed | KMT2B PDK3 APTX INTS1 MPDZ TTF1 CIC STAT1 SEMA4C RFTN1 PTPN13 SUPT6H SCD SGPL1 KMT2A UTRN TBP USP36 RAP1A NRAS MBOAT7 RBM4B NSD1 RPSA VIRMA CASK ACTR1A RNF2 POLR1E ZBED6 CFAP20 SEPTIN11 LSM14B EDRF1 | 1.58e-09 | 1497 | 243 | 34 | 31527615 | |
| Pubmed | 1.97e-09 | 9 | 243 | 5 | 22665483 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HSP90B1 ACLY SMC1A AZGP1 MCM7 UPF3B CMYA5 PGAM5 STAT1 RAB9A MAGED2 SUPT6H RAB3GAP2 DYNC1H1 GOLGA4 USP36 GPD2 RAP1B RBM4 IARS1 RPSA PRPF8 ACTR1A TGM3 PDE12 RNF2 ABCE1 VPS35 NAT10 SEC23IP UHRF1 GIGYF2 | 6.59e-09 | 1425 | 243 | 32 | 30948266 |
| Pubmed | SHANK proteins limit integrin activation by directly interacting with Rap1 and R-Ras. | 7.13e-09 | 11 | 243 | 5 | 28263956 | |
| Pubmed | ILDR2 HSP90B1 MYO7A ACLY TTC21A UPF3B RTN1 JMY SEPTIN8 SACS SGPL1 SYN1 SYN2 KMT2A KCNQ3 DMD UTRN DYNC1H1 GPD2 ANK3 MBOAT7 IARS1 ARFGEF2 NBEA RPSA VIRMA CASK ACTR1A ARHGAP5 VPS35 SEPTIN11 DNAH11 | 7.27e-09 | 1431 | 243 | 32 | 37142655 | |
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 7.43e-09 | 22 | 243 | 6 | 26886794 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | TRO ADAM9 NT5C3A INTS1 TTF1 SEMA4C SEPTIN8 RAB9A AGO3 VKORC1L1 NECTIN2 UGCG ANKIB1 TOR1B PMM2 GPD2 GAL3ST1 COG7 RBM4B ARFGEF2 TOR1A RANBP6 ECE1 TGFBR2 SEC23IP SEPTIN11 CDH17 | 8.61e-09 | 1061 | 243 | 27 | 33845483 |
| Pubmed | INTS1 MPDZ PTPN13 RAB3GAP2 SCN10A SYN1 SYN2 DMD DYNC1H1 ECE1 AP4E1 RNF2 PCNX4 VPS35 PAXIP1 | 1.02e-08 | 322 | 243 | 15 | 26514267 | |
| Pubmed | 1.16e-08 | 5 | 243 | 4 | 25561738 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | HSP90B1 SMC1A AZGP1 MPDZ UPF3B SPATA2 PGAM5 SUPT6H PYGL UTRN TBP USP36 USP13 IARS1 PRPF8 CCNA2 CASK TGM3 PDE12 POLR1E ABCE1 PRIM2 VPS35 GIGYF2 CDC25A CDC25B | 1.19e-08 | 1005 | 243 | 26 | 19615732 |
| Pubmed | 1.22e-08 | 12 | 243 | 5 | 27563068 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | KMT2B MYO7A ACLY TTC21A INTS1 ZBTB41 PGAM5 CHRNB4 UGCG SCN8A UTRN DYNC1H1 IPPK RB1 IARS1 TTI2 PCDHB12 NBEA PRPF8 ARHGAP5 PDE12 ABCE1 | 1.36e-08 | 736 | 243 | 22 | 29676528 |
| Pubmed | SETD1A KMT2B ACLY MPDZ MCM7 PGAM5 STAT1 PTPN13 RAB3GAP2 KMT2A DYNC1H1 ANK3 NSD1 SH3PXD2B KMT2D RNF2 NAT10 SEC23IP GIGYF2 | 1.39e-08 | 549 | 243 | 19 | 38280479 | |
| Pubmed | HSP90B1 PDK3 MPDZ PGAM5 PTPN13 SACS SUPT6H SCD RAB3GAP2 NECTIN2 GMDS DNA2 GOLGA4 NAA15 ERO1B ANK3 MBOAT7 TOR1A PON2 MRPL28 NR3C1 PRPF8 CASK NBAS PDE12 TIAM1 VPS35 NAT10 IFT122 MARVELD2 CRYBG3 EDRF1 | 1.79e-08 | 1487 | 243 | 32 | 33957083 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | HSP90B1 ACLY SMC1A NT5C3A INTS1 MCM7 PGAM5 STAT1 MAGED2 SCD HRAS GMDS PYGL DNA2 DYNC1H1 KRAS RAP1A RAP1B NRAS RBM4B RBM4 IARS1 RPSA PRPF8 ACTR1A GTF2H2 POLR1E ABCE1 AASS | 2.01e-08 | 1257 | 243 | 29 | 37317656 |
| Pubmed | Functional genomic landscape of cancer-intrinsic evasion of killing by T cells. | HSP90B1 SETD1B SPATA2 SCN8A KMT2A PMM2 ATG5 ATG7 PON2 AP4E1 GTF2H2 POLR1E AASS PRIM2 VPS35 NAT10 PAXIP1 | 2.91e-08 | 457 | 243 | 17 | 32968282 |
| Pubmed | 3.45e-08 | 6 | 243 | 4 | 9753431 | ||
| Pubmed | LZTR1 facilitates polyubiquitination and degradation of RAS-GTPases. | 3.45e-08 | 6 | 243 | 4 | 31337872 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | UAP1 MPDZ GIGYF1 PFKFB2 CIC PTPN13 KCNQ5 PIK3C2B RAB3GAP2 NECTIN2 KMT2A NR3C2 UTRN GOLGA4 NAA15 VIRMA SH3PXD2B TIAM1 AASS GIGYF2 CRYBG3 CDC25B EDRF1 | 4.90e-08 | 861 | 243 | 23 | 36931259 |
| Pubmed | 6.55e-08 | 16 | 243 | 5 | 24368734 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | HSP90B1 DCAF6 UAP1 ACLY ASH1L MCM7 SLC13A4 SCD SCN8A KMT2A UTRN DYNC1H1 GPD2 KRAS NRAS ANK3 IARS1 PRPF8 ACTR1A NBAS ABCE1 OSTF1 | 6.84e-08 | 807 | 243 | 22 | 30575818 |
| Pubmed | SMC1A AZGP1 INTS1 PFKFB3 SUPT6H DYNC1H1 USP13 DDX60 RPSA TGM3 RNF2 NAT10 ZNF654 | 7.43e-08 | 272 | 243 | 13 | 31010829 | |
| Pubmed | SmgGDS displays differential binding and exchange activity towards different Ras isoforms. | 8.00e-08 | 7 | 243 | 4 | 11948427 | |
| Pubmed | Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation. | 8.00e-08 | 7 | 243 | 4 | 35904492 | |
| Pubmed | ADAM9 MPDZ RTN1 PGAM5 AGO3 MAGED2 HRAS PLCB1 SYN1 DYNC1H1 GOLGA4 KRAS RAP1A ANK3 NSD1 NBEA VIRMA CASK ACTR1A SH3PXD2B NAT10 SEC23IP SEPTIN11 GIGYF2 | 8.95e-08 | 963 | 243 | 24 | 28671696 | |
| Pubmed | ACLY PGAM5 KDR DMD DDX60 NSD1 PRPF8 VIRMA KMT2D VPS35 NAT10 GIGYF2 | 1.11e-07 | 234 | 243 | 12 | 36243803 | |
| Pubmed | ABCC4 RTN1 SEMA4C PTPN13 SCD SGPL1 VKORC1L1 NECTIN2 GOLGA4 GPD2 MBOAT7 ARFGEF2 NBEA ECE1 NBAS VPS35 MARVELD2 | 1.18e-07 | 504 | 243 | 17 | 34432599 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | HSP90B1 DCAF6 ACLY SMC1A MCM7 CMYA5 STAT1 MAGED2 FDPS RAB3GAP2 GMDS PYGL DYNC1H1 ATG5 NAA15 ATG7 COG7 IARS1 ARFGEF2 RANBP6 RPSA NR3C1 ACTR1A PDE12 ABCE1 PRIM2 VPS35 SEC23IP SEPTIN11 DCTN3 | 1.31e-07 | 1455 | 243 | 30 | 22863883 |
| Pubmed | MYO7A CIC PLCB1 MBOAT7 RBM4 PON2 MRPL28 NBEA NR3C1 VIRMA KMT2D RNF2 POLR1E ABCE1 AASS SEC23IP PAXIP1 CDH17 DNAH11 | 1.46e-07 | 638 | 243 | 19 | 31182584 | |
| Pubmed | HSP90B1 ACLY SMC1A MCM7 PGAM5 MAGED2 SUPT6H DYNC1H1 NAA15 COG7 RBM4 IARS1 RPSA PRPF8 ACTR1A PRIM2 VPS35 NAT10 SEC23IP | 1.46e-07 | 638 | 243 | 19 | 33239621 | |
| Pubmed | 1.46e-07 | 57 | 243 | 7 | 18022353 | ||
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | TBKBP1 TDRD9 MCM7 GIGYF1 PGAM5 PHKA1 MAGED2 SUPT6H ANKIB1 KMT2A UQCRB IARS1 PRPF8 CCNA2 CASK CCNE2 GIGYF2 MAPK6 FBXO21 | 1.49e-07 | 639 | 243 | 19 | 23443559 |
| Pubmed | KMT2B ASH1L TTF1 UTRN DYNC1H1 USP13 ANK3 USB1 RBM4 ARFGEF2 RANBP6 CASK ARHGAP5 KMT2D CSH1 CSH2 VPS35 PAXIP1 | 2.26e-07 | 591 | 243 | 18 | 15231748 | |
| Pubmed | HSP90B1 ABCC4 ACLY INTS1 IRF4 MCM7 AGO3 MAGED2 SCD DYNC1H1 KRAS NAA15 NRAS MBOAT7 IARS1 DOCK10 ARFGEF2 RPSA CHST11 ECE1 PRPF8 NBAS ABCE1 NAT10 GIGYF2 IFT122 | 2.28e-07 | 1168 | 243 | 26 | 19946888 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | HSP90B1 SETD1B MPDZ CFB PHKA1 AGO3 SUPT6H SGPL1 SCN8A SCN9A PLCB1 C3 NAA15 SMG5 CASK ARHGAP5 | 2.86e-07 | 475 | 243 | 16 | 31040226 |
| Pubmed | Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis. | 2.94e-07 | 39 | 243 | 6 | 19738611 | |
| Pubmed | 2.96e-07 | 127 | 243 | 9 | 30442766 | ||
| Pubmed | 2.97e-07 | 21 | 243 | 5 | 24821722 | ||
| Pubmed | SETD1A KMT2B SMC1A ETV4 IRF4 GIGYF1 SPATA2 PGAM5 CIC STAT1 AGO3 MAGED2 KMT2A DYNC1H1 TBP RB1 RBM4 IARS1 MRPL28 RPSA SMG5 CCNA2 KMT2D RNF2 NAT10 PAXIP1 GIGYF2 ZMYM1 LSM14B | 3.01e-07 | 1429 | 243 | 29 | 35140242 | |
| Pubmed | 3.37e-07 | 3 | 243 | 3 | 33620658 | ||
| Pubmed | 3.37e-07 | 3 | 243 | 3 | 22589270 | ||
| Pubmed | 3.37e-07 | 3 | 243 | 3 | 25788415 | ||
| Pubmed | Partial functional overlap of the three ras genes in mouse embryonic development. | 3.37e-07 | 3 | 243 | 3 | 18059342 | |
| Pubmed | Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series. | 3.37e-07 | 3 | 243 | 3 | 23240926 | |
| Pubmed | Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma. | 3.37e-07 | 3 | 243 | 3 | 17712732 | |
| Pubmed | Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis. | 3.37e-07 | 3 | 243 | 3 | 22945650 | |
| Pubmed | 3.37e-07 | 3 | 243 | 3 | 19303097 | ||
| Pubmed | Absence of oncogenic mutations of RAS family genes in soft tissue sarcomas of 100 Japanese patients. | 3.37e-07 | 3 | 243 | 3 | 20150643 | |
| Pubmed | 3.37e-07 | 3 | 243 | 3 | 25977330 | ||
| Pubmed | 3.37e-07 | 3 | 243 | 3 | 28630043 | ||
| Pubmed | The variable phenotype and low-risk nature of RAS-positive thyroid nodules. | 3.37e-07 | 3 | 243 | 3 | 26253102 | |
| Pubmed | Analysis of k-ras nuclear expression in fibroblasts and mesangial cells. | 3.37e-07 | 3 | 243 | 3 | 20090846 | |
| Pubmed | Mutational analysis of K-ras and Ras protein expression in larynx squamous cell carcinoma. | 3.37e-07 | 3 | 243 | 3 | 16761621 | |
| Pubmed | 3.37e-07 | 3 | 243 | 3 | 20971740 | ||
| Pubmed | 3.37e-07 | 3 | 243 | 3 | 27119512 | ||
| Pubmed | Diagnostic Value of RAS Mutations in Indeterminate Thyroid Nodules. | 3.37e-07 | 3 | 243 | 3 | 28116986 | |
| Pubmed | 3.37e-07 | 3 | 243 | 3 | 31754018 | ||
| Pubmed | Mutations of RAS gene family in specimens of bladder cancer. | 3.37e-07 | 3 | 243 | 3 | 19101897 | |
| Pubmed | The decrease of mineralcorticoid receptor drives angiogenic pathways in colorectal cancer. | 3.37e-07 | 3 | 243 | 3 | 23555666 | |
| Pubmed | A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation. | 3.37e-07 | 3 | 243 | 3 | 23496764 | |
| Pubmed | Distribution of p21ras during primary palate formation of non-cleft and cleft strains of mice. | 3.37e-07 | 3 | 243 | 3 | 7776260 | |
| Pubmed | Comparison of liver oncogenic potential among human RAS isoforms. | 3.37e-07 | 3 | 243 | 3 | 26799184 | |
| Pubmed | 3.37e-07 | 3 | 243 | 3 | 31906952 | ||
| Pubmed | 3.37e-07 | 3 | 243 | 3 | 18786918 | ||
| Pubmed | Absolute Quantification of Endogenous Ras Isoform Abundance. | 3.37e-07 | 3 | 243 | 3 | 26560143 | |
| Pubmed | 3.37e-07 | 3 | 243 | 3 | 24222113 | ||
| Pubmed | 3.37e-07 | 3 | 243 | 3 | 27911734 | ||
| Pubmed | K-ras is an essential gene in the mouse with partial functional overlap with N-ras. | 3.37e-07 | 3 | 243 | 3 | 9334313 | |
| Pubmed | RAS gene mutations and histomorphometric measurements in oral squamous cell carcinoma. | 3.37e-07 | 3 | 243 | 3 | 37013448 | |
| Pubmed | Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer. | 3.37e-07 | 3 | 243 | 3 | 28259994 | |
| Pubmed | 3.37e-07 | 3 | 243 | 3 | 16573741 | ||
| Pubmed | 3.37e-07 | 3 | 243 | 3 | 21737741 | ||
| Pubmed | 3.37e-07 | 3 | 243 | 3 | 17943694 | ||
| Pubmed | 3.37e-07 | 3 | 243 | 3 | 26969140 | ||
| Pubmed | 3.37e-07 | 3 | 243 | 3 | 28202657 | ||
| Pubmed | 3.37e-07 | 3 | 243 | 3 | 33567280 | ||
| Pubmed | HSP90B1 NT5C3A MCM7 PFKFB3 PGAM5 JMY SGPL1 FDPS TRAPPC4 KMT2A RAB27A DYNC1H1 TBP GPD2 KRAS COG7 DDX60 TTI2 PON2 RANBP6 MRPL28 PRPF8 CCNA2 ACTR1A NBAS AASS CCNE2 VPS35 NAT10 | 3.52e-07 | 1440 | 243 | 29 | 30833792 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | ADAM9 RFTN1 PTPN13 NECTIN2 UGCG PLCB1 DMD UTRN RAP1B ANK3 DOCK10 CASK TIAM1 SEPTIN11 | 5.08e-07 | 377 | 243 | 14 | 38117590 |
| Pubmed | ACLY SMC1A MCM7 MAGED2 SUPT6H SGPL1 RAB3GAP2 DYNC1H1 GPD2 COG7 PON2 MRPL28 PRPF8 CASK PDE12 VPS35 SEC23IP | 5.16e-07 | 560 | 243 | 17 | 35241646 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | ACLY INTS1 STAT1 MAGED2 SACS SGPL1 RAB3GAP2 SYN1 PYGL NBEA PRPF8 CASK SH3PXD2B PDE12 NAT10 SEPTIN11 | 5.36e-07 | 498 | 243 | 16 | 36634849 |
| Pubmed | SETD1A HSP90B1 SETD1B KMT2B KMT2A C3 HEPHL1 UTRN DYNC1H1 USP36 NAA15 IARS1 RPSA PRPF8 ACTR1A KMT2D PDE12 ABCE1 NAT10 | 7.47e-07 | 711 | 243 | 19 | 33022573 | |
| Pubmed | ACLY INTS1 TTF1 PGAM5 SUPT6H KMT2A PYGL UTRN DYNC1H1 NAA15 NSD1 RPSA PRPF8 VIRMA TGM3 ABCE1 NAT10 GIGYF2 | 9.50e-07 | 653 | 243 | 18 | 22586326 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ACLY SEPTIN8 PTPN13 AGO3 USP36 RBM4 IARS1 DDX60 RPSA SMG5 PRPF8 SH3PXD2B RNF2 NAT10 SERPINB2 SEPTIN11 GIGYF2 ZMYM1 LSM14B | 9.77e-07 | 724 | 243 | 19 | 36232890 |
| Pubmed | 1.10e-06 | 12 | 243 | 4 | 22919064 | ||
| Pubmed | 1.19e-06 | 49 | 243 | 6 | 23397142 | ||
| Pubmed | CEP104 ADAM9 SEMA4C SCD VKORC1L1 NECTIN2 HRAS PLCB1 KRAS NRAS MBOAT7 ECE1 TIAM1 SEC23IP MARVELD2 | 1.22e-06 | 467 | 243 | 15 | 30194290 | |
| Pubmed | 1.34e-06 | 4 | 243 | 3 | 9674433 | ||
| Pubmed | Reducing Pericyte-Derived Scarring Promotes Recovery after Spinal Cord Injury. | 1.34e-06 | 4 | 243 | 3 | 29502968 | |
| Pubmed | 1.34e-06 | 4 | 243 | 3 | 10490827 | ||
| Pubmed | Ras membrane orientation and nanodomain localization generate isoform diversity. | 1.34e-06 | 4 | 243 | 3 | 20080631 | |
| Pubmed | VEGF-induced neoangiogenesis is mediated by NAADP and two-pore channel-2-dependent Ca2+ signaling. | 1.34e-06 | 4 | 243 | 3 | 25331892 | |
| Pubmed | 1.34e-06 | 4 | 243 | 3 | 10085069 | ||
| Pubmed | 1.34e-06 | 4 | 243 | 3 | 38849523 | ||
| Pubmed | A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity. | 1.34e-06 | 4 | 243 | 3 | 23129768 | |
| Interaction | PAXIP1 interactions | SETD1A SETD1B KMT2B SMC1A ETV4 IRF4 PGAM5 CIC RAB3GAP2 KMT2A NR3C1 PRPF8 VIRMA CRX KMT2D RNF2 POLR1E PAXIP1 CATSPERG | 7.16e-08 | 359 | 241 | 19 | int:PAXIP1 |
| Interaction | KMT2D interactions | SETD1A SETD1B KMT2B ETV4 IRF4 KMT2A NR3C1 VIRMA CRX KMT2D RNF2 PAXIP1 CHEK2 | 1.31e-07 | 169 | 241 | 13 | int:KMT2D |
| Interaction | LYN interactions | ILDR2 HSP90B1 INPP5D UPF3B SEMA4C RFTN1 PTPN13 NECTIN2 HRAS PLCB1 KMT2A MME DMD DNA2 UTRN KRAS RAP1A NRAS ANK3 ATG7 PRPF8 VIRMA CASK TIAM1 ABCE1 DENND2C MARVELD2 | 1.61e-07 | 720 | 241 | 27 | int:LYN |
| Interaction | RAPGEF6 interactions | 3.83e-07 | 78 | 241 | 9 | int:RAPGEF6 | |
| Interaction | CTNNB1 interactions | HSP90B1 MYO7A ACLY MPDZ MCM7 PFKFB3 STAT1 PTPN13 HRAS CCNA1 KMT2A KDR UQCRB UTRN DYNC1H1 USP36 KRAS USP13 NAA15 NRAS ANK3 ARFGEF2 RPSA NR3C1 VIRMA CCNA2 TGFBR2 ARHGAP5 KMT2D ABCE1 AASS MAPK6 | 4.74e-07 | 1009 | 241 | 32 | int:CTNNB1 |
| Interaction | KDM6A interactions | SETD1A SETD1B KMT2B ETV4 IRF4 KMT2A NR3C1 VIRMA CRX KMT2D RNF2 PAXIP1 | 6.01e-07 | 162 | 241 | 12 | int:KDM6A |
| Interaction | PDLIM4 interactions | 6.59e-07 | 27 | 241 | 6 | int:PDLIM4 | |
| Interaction | TIAM1 interactions | ABCA1 GIGYF1 HRAS DMD ATG5 KRAS NRAS ANK3 VIRMA CASK TIAM1 GIGYF2 CDC25B | 1.20e-06 | 205 | 241 | 13 | int:TIAM1 |
| Interaction | NCOA6 interactions | SETD1A SETD1B KMT2B KMT2A TBP RB1 NR3C1 VIRMA KMT2D RNF2 PAXIP1 | 1.41e-06 | 145 | 241 | 11 | int:NCOA6 |
| Interaction | RGL1 interactions | 1.77e-06 | 18 | 241 | 5 | int:RGL1 | |
| Interaction | KDM5A interactions | 2.84e-06 | 74 | 241 | 8 | int:KDM5A | |
| Interaction | RALGPS2 interactions | 3.52e-06 | 54 | 241 | 7 | int:RALGPS2 | |
| Interaction | KMT2B interactions | SETD1A SETD1B KMT2B SEPTIN8 KMT2A RAP1B ATG7 VIRMA KMT2D PAXIP1 | 3.77e-06 | 130 | 241 | 10 | int:KMT2B |
| Interaction | MCAM interactions | ADAM9 RFTN1 PTPN13 RAB9A NECTIN2 UGCG HRAS PLCB1 DMD UTRN KRAS RAP1B NRAS ANK3 DOCK10 VIRMA CASK TIAM1 SEPTIN11 | 3.90e-06 | 468 | 241 | 19 | int:MCAM |
| Interaction | FBXW7 interactions | HSP90B1 ACLY SMC1A MCM7 PGAM5 STAT1 MAGED2 SUPT6H SGPL1 HRAS KMT2A GMDS PYGL C3 DYNC1H1 PMM2 ATG5 USP36 KRAS IARS1 NR3C1 PRPF8 VIRMA TGM3 KMT2D RNF2 CCNE2 VPS35 NAT10 PAXIP1 UHRF1 GIGYF2 LSM14B | 8.86e-06 | 1215 | 241 | 33 | int:FBXW7 |
| Interaction | E2F6 interactions | 1.47e-05 | 185 | 241 | 11 | int:E2F6 | |
| Interaction | ATG2A interactions | 1.51e-05 | 45 | 241 | 6 | int:ATG2A | |
| Interaction | PLEKHA2 interactions | 1.71e-05 | 94 | 241 | 8 | int:PLEKHA2 | |
| Interaction | DIRAS3 interactions | ILDR2 SEMA4C PTPN13 MAGED2 NECTIN2 HRAS GOLGA4 KRAS ANK3 NBEA TIAM1 CHEK2 MARVELD2 | 1.74e-05 | 262 | 241 | 13 | int:DIRAS3 |
| Interaction | LIMA1 interactions | GIGYF1 PGAM5 CIC STAT1 UTRN KRAS RAP1A RAP1B RPSA PRPF8 VIRMA RNF2 TIAM1 PAXIP1 DYNLT5 GIGYF2 CDC25B | 1.74e-05 | 429 | 241 | 17 | int:LIMA1 |
| Interaction | RASAL2 interactions | 2.11e-05 | 158 | 241 | 10 | int:RASAL2 | |
| Interaction | RAB7A interactions | HSP90B1 ABCC4 RTN1 SEMA4C PTPN13 RAB9A SCD SGPL1 VKORC1L1 NECTIN2 HRAS GOLGA4 GPD2 KRAS RAP1A RAP1B ATG7 MBOAT7 ARFGEF2 NBEA ECE1 VIRMA TGFBR2 NBAS VPS35 MARVELD2 | 2.37e-05 | 886 | 241 | 26 | int:RAB7A |
| Interaction | ARF6 interactions | UPF3B SEMA4C RFTN1 NECTIN2 PLCB1 DMD DYNC1H1 ATG5 KRAS RAP1B NRAS ANK3 MBOAT7 NR3C1 ECE1 CASK AP4E1 TIAM1 SEPTIN11 MARVELD2 | 2.62e-05 | 584 | 241 | 20 | int:ARF6 |
| Interaction | POLR2A interactions | SETD1A MAGEA11 SETD1B SMC1A INTS1 MCM7 CIC SUPT6H KMT2A TBP KRAS NSD1 VIRMA KMT2D RNF2 CSH1 CSH2 POLR1E MAPK6 | 2.62e-05 | 536 | 241 | 19 | int:POLR2A |
| Interaction | GAB2 interactions | 2.70e-05 | 130 | 241 | 9 | int:GAB2 | |
| Interaction | EP300 interactions | SETD1A MAGEA11 ACLY SMC1A ETV4 IRF4 MCM7 PGAM5 JMY STAT1 SEPTIN8 SUPT6H CCNA1 C3 NR3C2 DNA2 TBP NAA15 ATG7 RB1 RBM4 NR3C1 PRPF8 VIRMA CCNA2 CRX KMT2D PDE12 ABCE1 VPS35 NAT10 PAXIP1 SEPTIN11 ATF4 CDC25A | 2.73e-05 | 1401 | 241 | 35 | int:EP300 |
| Interaction | ZDHHC18 interactions | 2.92e-05 | 74 | 241 | 7 | int:ZDHHC18 | |
| Interaction | NF1 interactions | GIGYF1 SEMA4C PTPN13 HRAS KRAS NRAS ATG7 NR3C1 VIRMA TIAM1 GIGYF2 CDC25B | 3.13e-05 | 238 | 241 | 12 | int:NF1 |
| Interaction | PRKCD interactions | TRO ADAM9 INPP5D STAT1 PIK3CB PLCB1 DYNC1H1 NRAS ATG7 TIAM1 CDC25A CDC25B | 3.13e-05 | 238 | 241 | 12 | int:PRKCD |
| Interaction | SETD1B interactions | 3.19e-05 | 75 | 241 | 7 | int:SETD1B | |
| Interaction | HEPH interactions | 3.29e-05 | 6 | 241 | 3 | int:HEPH | |
| Interaction | KMT2C interactions | 3.44e-05 | 134 | 241 | 9 | int:KMT2C | |
| Interaction | SMC3 interactions | SETD1A HSP90B1 SMC1A AZGP1 INTS1 CIC RAB9A DYNC1H1 KRAS USP13 DDX60 VIRMA RNF2 NAT10 PAXIP1 CHEK2 | 3.50e-05 | 408 | 241 | 16 | int:SMC3 |
| Interaction | NRAS interactions | CEP104 ACLY ADAM9 RTN1 SEMA4C SEPTIN8 SCD VKORC1L1 NECTIN2 HRAS PLCB1 RAB27A KRAS NRAS MBOAT7 ARFGEF2 ECE1 TIAM1 ABCE1 SEC23IP SEPTIN11 MARVELD2 | 3.70e-05 | 699 | 241 | 22 | int:NRAS |
| Interaction | FKBP5 interactions | MAGEA11 MCM7 AGO3 MAGED2 SACS PYGL NR3C2 UQCRB DNA2 ATG5 COL6A6 ATG7 NR3C1 PRPF8 ABCE1 NAT10 | 4.17e-05 | 414 | 241 | 16 | int:FKBP5 |
| Interaction | USP7 interactions | ABCA1 ACLY TRO UPF3B CIC PHKA1 RAB9A MAGED2 SYN1 SHE KDR DMD UTRN DYNC1H1 USP36 KRAS MRAS RB1 DDX60 DOCK10 NSD1 PRPF8 VIRMA KMT2D RNF2 ABCE1 VPS35 NAT10 CHEK2 UHRF1 GIGYF2 ZMYM1 CDC25A | 4.22e-05 | 1313 | 241 | 33 | int:USP7 |
| Interaction | HM13 interactions | 4.33e-05 | 138 | 241 | 9 | int:HM13 | |
| Interaction | NR3C1 interactions | MAGEA11 HSP90B1 DCAF6 MYO7A SMC1A CIC PLCB1 C3 NR3C2 TBP MBOAT7 RBM4 PON2 MRPL28 NBEA NR3C1 VIRMA KMT2D RNF2 POLR1E ABCE1 AASS SEC23IP PAXIP1 UHRF1 CDH17 DNAH11 | 4.39e-05 | 974 | 241 | 27 | int:NR3C1 |
| Interaction | RICTOR interactions | HSP90B1 ACLY AZGP1 STAT1 RAB3GAP2 HRAS UTRN DYNC1H1 GPD2 KRAS NAA15 NRAS MBOAT7 IARS1 ARFGEF2 VIRMA ACTR1A TGM3 EFNA5 RNF2 SEC23IP GIGYF2 MAPK6 | 4.40e-05 | 759 | 241 | 23 | int:RICTOR |
| Interaction | RBBP5 interactions | SETD1A SETD1B KMT2B KMT2A USP36 KRAS RB1 VIRMA CRX KMT2D RNF2 NAT10 PAXIP1 | 4.49e-05 | 287 | 241 | 13 | int:RBBP5 |
| Interaction | SRC interactions | INPP5D DAB1 MCM7 CIC STAT1 RAB9A KCNQ5 HRAS CCNA1 SYN1 KMT2A KDR KRAS NRAS NR3C1 EFNA5 TIAM1 GUCY2C ABCE1 OSTF1 CDC25A | 5.22e-05 | 664 | 241 | 21 | int:SRC |
| Interaction | KTI12 interactions | 5.68e-05 | 35 | 241 | 5 | int:KTI12 | |
| Interaction | PHLDB2 interactions | 5.72e-05 | 143 | 241 | 9 | int:PHLDB2 | |
| Interaction | POLD1 interactions | HSP90B1 MCM7 UPF3B PGAM5 CIC TBP KRAS ATG7 RB1 MRPL28 CCNA2 RNF2 PRIM2 MAPK6 | 5.87e-05 | 337 | 241 | 14 | int:POLD1 |
| Interaction | AR interactions | MAGEA11 DCAF6 ACLY SMC1A MCM7 PGAM5 CIC KMT2A SHE NR3C2 MME DYNC1H1 TBP RAP1A RB1 IARS1 NSD1 NR3C1 PRPF8 VIRMA KMT2D GTF2H2 RNF2 PAXIP1 UHRF1 CDC25A CDC25B | 6.00e-05 | 992 | 241 | 27 | int:AR |
| Interaction | RALGDS interactions | 6.53e-05 | 36 | 241 | 5 | int:RALGDS | |
| Interaction | NUP155 interactions | RTN1 CIC RAB9A RAB3GAP2 C3 KDR RAB27A GOLGA4 KRAS MBOAT7 DDX60 PRPF8 VIRMA NBAS KMT2D SEC23IP CRYBG3 | 6.57e-05 | 477 | 241 | 17 | int:NUP155 |
| Interaction | USP32 interactions | 6.89e-05 | 114 | 241 | 8 | int:USP32 | |
| Interaction | STIP1 interactions | HSP90B1 PDK3 ACLY SMC1A MCM7 PGAM5 MAGED2 SUPT6H DYNC1H1 NAA15 COG7 RBM4 IARS1 DDX60 RPSA PRPF8 VIRMA LRRC9 ACTR1A KCNQ4 NEK8 PRIM2 VPS35 NAT10 SEC23IP MAPK6 CDC25A | 7.59e-05 | 1006 | 241 | 27 | int:STIP1 |
| Interaction | TMEM165 interactions | 7.79e-05 | 116 | 241 | 8 | int:TMEM165 | |
| Interaction | BOD1L1 interactions | 7.87e-05 | 149 | 241 | 9 | int:BOD1L1 | |
| Interaction | SDF4 interactions | 8.72e-05 | 151 | 241 | 9 | int:SDF4 | |
| Interaction | RPAP3 interactions | CEP104 INTS1 SUPT6H KRAS TTI2 PRPF8 CCNA2 ACTR1A POLR1E NEK8 SEC23IP | 8.83e-05 | 225 | 241 | 11 | int:RPAP3 |
| Interaction | SEPTIN6 interactions | 8.94e-05 | 88 | 241 | 7 | int:SEPTIN6 | |
| Interaction | CCDC171 interactions | 9.05e-05 | 8 | 241 | 3 | int:CCDC171 | |
| Interaction | FANCC interactions | 9.60e-05 | 89 | 241 | 7 | int:FANCC | |
| Interaction | SEPTIN5 interactions | 9.65e-05 | 62 | 241 | 6 | int:SEPTIN5 | |
| Interaction | RAPGEF1 interactions | 9.69e-05 | 39 | 241 | 5 | int:RAPGEF1 | |
| Interaction | SNTB1 interactions | 1.06e-04 | 63 | 241 | 6 | int:SNTB1 | |
| Interaction | PLCB1 interactions | 1.06e-04 | 63 | 241 | 6 | int:PLCB1 | |
| Interaction | C9orf72 interactions | HSP90B1 TBKBP1 ACLY SMC1A NT5C3A INTS1 MCM7 PGAM5 STAT1 RAB9A MAGED2 SCD HRAS GMDS PYGL DNA2 DYNC1H1 KRAS RAP1A RAP1B NRAS RBM4B RBM4 IARS1 RPSA PRPF8 CRX ACTR1A GTF2H2 POLR1E ABCE1 AASS | 1.08e-04 | 1319 | 241 | 32 | int:C9orf72 |
| Interaction | PCNA interactions | HSP90B1 ACLY MCM7 PIK3CB MME DNTT USP36 KRAS RAP1B ANK3 RPSA VIRMA CCNA2 CCNE2 PRIM2 SEC23IP UHRF1 | 1.08e-04 | 497 | 241 | 17 | int:PCNA |
| Interaction | SEPTIN11 interactions | 1.11e-04 | 122 | 241 | 8 | int:SEPTIN11 | |
| Interaction | WDR6 interactions | RAB9A UTRN USP36 KRAS NRAS ATG7 TGFBR2 RNF2 POLR1E ABCE1 MAPK6 CDC25A CDC25B | 1.11e-04 | 314 | 241 | 13 | int:WDR6 |
| Interaction | TMT1A interactions | CCDC168 RTN1 SEMA4C KCNQ5 RAB3GAP2 NECTIN2 MME RAB27A GOLGA4 MBOAT7 NR3C1 NBAS SEC23IP SERPINB2 | 1.15e-04 | 359 | 241 | 14 | int:TMT1A |
| Interaction | PPM1H interactions | 1.18e-04 | 123 | 241 | 8 | int:PPM1H | |
| Interaction | DOCK8 interactions | 1.18e-04 | 123 | 241 | 8 | int:DOCK8 | |
| Interaction | HCFC2 interactions | 1.18e-04 | 92 | 241 | 7 | int:HCFC2 | |
| Interaction | CTNNAL1 interactions | 1.26e-04 | 65 | 241 | 6 | int:CTNNAL1 | |
| Interaction | ZNF608 interactions | 1.27e-04 | 93 | 241 | 7 | int:ZNF608 | |
| Interaction | CDC6 interactions | 1.32e-04 | 125 | 241 | 8 | int:CDC6 | |
| Interaction | WDR5 interactions | SETD1A HSP90B1 DCAF6 SETD1B KMT2B ACLY CIC KMT2A C3 HEPHL1 UTRN DYNC1H1 TBP USP36 NAA15 IARS1 RPSA PRPF8 ACTR1A KMT2D PDE12 RNF2 POLR1E ABCE1 VPS35 NAT10 PAXIP1 GIGYF2 | 1.39e-04 | 1101 | 241 | 28 | int:WDR5 |
| Interaction | ELF1 interactions | 1.39e-04 | 126 | 241 | 8 | int:ELF1 | |
| Interaction | YWHAH interactions | UAP1 MPDZ GIGYF1 PFKFB2 PFKFB3 CIC PTPN13 KCNQ5 PIK3C2B RAB3GAP2 NECTIN2 KMT2A NR3C2 UTRN GOLGA4 KRAS NR3C1 VIRMA SH3PXD2B TIAM1 ABCE1 AASS DENND2C GIGYF2 CRYBG3 CDC25A CDC25B EDRF1 | 1.41e-04 | 1102 | 241 | 28 | int:YWHAH |
| Interaction | RP2 interactions | 1.45e-04 | 95 | 241 | 7 | int:RP2 | |
| Interaction | KAT8 interactions | 1.45e-04 | 95 | 241 | 7 | int:KAT8 | |
| Interaction | SLC23A2 interactions | 1.48e-04 | 23 | 241 | 4 | int:SLC23A2 | |
| Interaction | MCM7 interactions | SETD1A ACLY SMC1A MCM7 USP36 KRAS RB1 RANBP6 VIRMA ACTR1A RNF2 POLR1E VPS35 CHEK2 MAPK6 | 1.48e-04 | 414 | 241 | 15 | int:MCM7 |
| Interaction | RNF123 interactions | KMT2B MYO7A ACLY TTC21A INTS1 ZBTB41 PGAM5 CHRNB4 UGCG SCN8A UTRN DYNC1H1 IPPK RB1 IARS1 TTI2 PCDHB12 NBEA NR3C1 PRPF8 ARHGAP5 PDE12 ABCE1 | 1.50e-04 | 824 | 241 | 23 | int:RNF123 |
| Interaction | SMC4 interactions | ACLY SMC1A GOLGA4 KRAS ATG7 PRPF8 VIRMA ACTR1A RNF2 ABCE1 CHEK2 CDC25B | 1.53e-04 | 281 | 241 | 12 | int:SMC4 |
| Interaction | TRAPPC11 interactions | 1.55e-04 | 96 | 241 | 7 | int:TRAPPC11 | |
| Interaction | SH3PXD2A interactions | 1.55e-04 | 128 | 241 | 8 | int:SH3PXD2A | |
| Interaction | LAMTOR1 interactions | TBKBP1 SEMA4C RFTN1 RAB9A PIK3C2B NECTIN2 HRAS MME DMD GOLGA4 KRAS NRAS ARFGEF2 NBEA ECE1 CASK AP4E1 SEC23IP MARVELD2 CRYBG3 EDRF1 | 1.68e-04 | 722 | 241 | 21 | int:LAMTOR1 |
| Interaction | KRIT1 interactions | 1.74e-04 | 44 | 241 | 5 | int:KRIT1 | |
| Interaction | KCNQ3 interactions | 1.76e-04 | 24 | 241 | 4 | int:KCNQ3 | |
| Interaction | DPY30 interactions | SETD1A SETD1B KMT2B KMT2A KRAS ARFGEF2 NR3C1 VIRMA KMT2D PAXIP1 | 1.80e-04 | 204 | 241 | 10 | int:DPY30 |
| Interaction | RASA1 interactions | 1.87e-04 | 167 | 241 | 9 | int:RASA1 | |
| Interaction | TRPV2 interactions | 1.90e-04 | 10 | 241 | 3 | int:TRPV2 | |
| Interaction | NBPF15 interactions | 1.90e-04 | 10 | 241 | 3 | int:NBPF15 | |
| Interaction | CXXC1 interactions | 1.92e-04 | 132 | 241 | 8 | int:CXXC1 | |
| Interaction | DNAJC7 interactions | TDRD9 PFKFB3 CIC SACS NR3C2 DNA2 DDX60 NR3C1 PRPF8 TGFBR2 ABCE1 NEK8 IFT122 MAPK6 EDRF1 | 1.96e-04 | 425 | 241 | 15 | int:DNAJC7 |
| Interaction | SIRPA interactions | 2.00e-04 | 100 | 241 | 7 | int:SIRPA | |
| Interaction | WEE1 interactions | 2.02e-04 | 133 | 241 | 8 | int:WEE1 | |
| Interaction | ST14 interactions | ADAM9 NECTIN2 SEL1L3 HRAS ST8SIA5 KRAS ERO1B TOR1A EFNA5 CHEK2 | 2.03e-04 | 207 | 241 | 10 | int:ST14 |
| Interaction | HSP90B2P interactions | 2.07e-04 | 25 | 241 | 4 | int:HSP90B2P | |
| Interaction | SETD1A interactions | 2.14e-04 | 170 | 241 | 9 | int:SETD1A | |
| Interaction | VPS18 interactions | 2.24e-04 | 135 | 241 | 8 | int:VPS18 | |
| Interaction | FGFR1 interactions | PFKFB3 RTN1 SEPTIN8 PTPN13 RAB9A FDPS RAB3GAP2 TRAPPC4 SHE UTRN RAP1A ANK3 NBEA VIRMA CASK TGFBR2 SH3PXD2B SEC23IP SEPTIN11 | 2.28e-04 | 632 | 241 | 19 | int:FGFR1 |
| Interaction | GJA1 interactions | ILDR2 SEMA4C PTPN13 NECTIN2 C3 UTRN GOLGA4 ATG5 KRAS NRAS ANK3 NBEA CASK AP4E1 NBAS TIAM1 SEC23IP MARVELD2 | 2.42e-04 | 583 | 241 | 18 | int:GJA1 |
| Interaction | RASA2 interactions | 2.42e-04 | 26 | 241 | 4 | int:RASA2 | |
| Cytoband | Xp11.22-p11.21 | 1.66e-04 | 4 | 243 | 2 | Xp11.22-p11.21 | |
| Cytoband | 3p22.2 | 2.73e-04 | 24 | 243 | 3 | 3p22.2 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 2.81e-08 | 34 | 173 | 7 | 487 | |
| GeneFamily | RAS type GTPase family | 4.25e-07 | 31 | 173 | 6 | 389 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 6.93e-05 | 9 | 173 | 3 | 1203 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 8.75e-05 | 25 | 173 | 4 | 775 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 1.60e-04 | 29 | 173 | 4 | 396 | |
| GeneFamily | PHD finger proteins | 2.25e-04 | 90 | 173 | 6 | 88 | |
| GeneFamily | Synapsins | 2.71e-04 | 3 | 173 | 2 | 1325 | |
| GeneFamily | Class III Cys-based CDC25 phosphatases | 2.71e-04 | 3 | 173 | 2 | 713 | |
| GeneFamily | 6-phosphofructo-2-kinases/fructose-2,6-biphosphatases | 5.39e-04 | 4 | 173 | 2 | 1077 | |
| GeneFamily | Potassium voltage-gated channels | 5.66e-04 | 40 | 173 | 4 | 274 | |
| GeneFamily | Growth hormone family | 1.33e-03 | 6 | 173 | 2 | 1175 | |
| GeneFamily | Cyclins | 2.37e-03 | 28 | 173 | 3 | 473 | |
| GeneFamily | Phosphatidylinositol 3-kinase subunits | 2.45e-03 | 8 | 173 | 2 | 831 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 3.14e-03 | 9 | 173 | 2 | 1230 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_DN | ABCA1 INPP5D IRF4 PIK3CB MME MRAS CCNA2 SERPINB2 GIGYF2 OSTF1 ZNF654 CDH17 | 3.63e-07 | 198 | 243 | 12 | M5776 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RFTN1 PTPN13 SACS UGCG DMD GOLGA4 NSMAF PMM2 USP13 RAP1A RB1 NR3C1 CASK TGFBR2 NBAS EFNA5 RNF2 TIAM1 ABCE1 PRIM2 SERPINB2 GIGYF2 CRYBG3 MAPK6 | 1.63e-06 | 856 | 243 | 24 | M4500 |
| Coexpression | GSE6875_TCONV_VS_FOXP3_KO_TREG_DN | HSP90B1 UPF3B TM6SF1 SEMA4C RAB3GAP2 DNA2 UTRN NSMAF RB1 NBEA GTF2H2 | 2.89e-06 | 200 | 243 | 11 | M6802 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | ABCC4 ADAM9 INTS1 PFKFB2 TTF1 SACS SCD RAB3GAP2 SEL1L3 SCN9A KMT2A TOR1B UQCRB DYNC1H1 GOLGA4 ERO1B IARS1 ARFGEF2 TOR1A CHST11 NR3C1 PRPF8 PDE12 CFAP20 PAXIP1 SEPTIN11 OSTF1 EDRF1 DCTN3 | 3.22e-06 | 1215 | 243 | 29 | M41122 |
| Coexpression | PATIL_LIVER_CANCER | ACLY DAB1 ETV4 SCD FDPS RAB3GAP2 SCN8A ANKIB1 UQCRB DYNC1H1 MBOAT7 IARS1 RPSA SMG5 CCNA2 SH3PXD2B PRIM2 LSM14B CDC25A CDC25B | 4.00e-06 | 660 | 243 | 20 | M1195 |
| Coexpression | LEE_BMP2_TARGETS_DN | UAP1 NT5C3A MCM7 PGAM5 SACS VKORC1L1 TRAPPC4 DNA2 VEGFA NAA15 IARS1 PDE12 TIAM1 POLR1E ABCE1 AASS CCNE2 NAT10 SEC23IP PAXIP1 UHRF1 ZMYM1 MAPK6 CDC25A | 4.15e-06 | 904 | 243 | 24 | M2325 |
| Coexpression | LEE_BMP2_TARGETS_DN | UAP1 NT5C3A MCM7 PGAM5 SACS VKORC1L1 TRAPPC4 DNA2 VEGFA NAA15 IARS1 PDE12 TIAM1 POLR1E ABCE1 AASS CCNE2 NAT10 SEC23IP PAXIP1 UHRF1 ZMYM1 MAPK6 CDC25A | 5.78e-06 | 922 | 243 | 24 | MM1068 |
| Coexpression | PUJANA_ATM_PCC_NETWORK | SETD1A INPP5D SMC1A INTS1 IRF4 PFKFB2 PFKFB3 STAT1 RFTN1 SGPL1 RAB3GAP2 DNA2 NSMAF TBP PMM2 GPD2 RAP1A RAP1B NRAS RB1 DOCK10 ARFGEF2 NR3C1 CCNA2 GTF2H2 TIAM1 ABCE1 SEC23IP PAXIP1 CHEK2 OSTF1 | 6.06e-06 | 1394 | 243 | 31 | M9585 |
| Coexpression | RUIZ_TNC_TARGETS_DN | 7.91e-06 | 143 | 243 | 9 | M19048 | |
| Coexpression | BENPORATH_CYCLING_GENES | CIC STAT1 ME3 HRAS DNA2 KRAS USP13 USB1 ZPBP NR3C1 CCNA2 CSH2 CCNE2 PRIM2 CHEK2 UHRF1 ZMYM1 CDC25A CDC25B | 1.11e-05 | 648 | 243 | 19 | M8156 |
| Coexpression | VEGF_A_UP.V1_DN | 1.38e-05 | 193 | 243 | 10 | M2675 | |
| Coexpression | BAELDE_DIABETIC_NEPHROPATHY_DN | HSP90B1 UAP1 STAT1 NECTIN2 UGCG GMDS MME CMAHP VEGFA IARS1 NR3C1 ARHGAP5 AASS SEPTIN11 FBXO21 | 1.59e-05 | 437 | 243 | 15 | M4665 |
| Coexpression | GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_DN | ABCC4 ABCA1 TM6SF1 KCNQ5 SGPL1 IARS1 CHST11 ABCE1 NAT10 SEPTIN11 | 1.65e-05 | 197 | 243 | 10 | M8561 |
| Coexpression | DOANE_RESPONSE_TO_ANDROGEN_DN | RTN1 SEPTIN8 RFTN1 SUPT6H PLCB1 TIAM1 CSH2 CCNE2 LPIN2 IFT122 CDC25A | 1.76e-05 | 242 | 243 | 11 | M12816 |
| Coexpression | GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_DN | 1.80e-05 | 199 | 243 | 10 | M3486 | |
| Coexpression | GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_UP | 1.80e-05 | 199 | 243 | 10 | M5205 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_UP | SMC1A RAB3GAP2 UGCG SEL1L3 PMM2 USP36 KRAS NAA15 DOCK10 TGFBR2 | 1.88e-05 | 200 | 243 | 10 | M8026 |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_DN | 1.88e-05 | 200 | 243 | 10 | M9327 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_DN | 1.88e-05 | 200 | 243 | 10 | M9688 | |
| Coexpression | GSE7852_LN_VS_THYMUS_TREG_UP | 1.88e-05 | 200 | 243 | 10 | M5737 | |
| Coexpression | GSE8621_LPS_PRIMED_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN | MYO7A ACLY TM6SF1 SACS PLCB1 FASTKD3 GAL3ST1 CASK CDC25A ZNF654 | 1.88e-05 | 200 | 243 | 10 | M6975 |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | HSP90B1 DCAF6 SMC1A MCM7 UPF3B TM6SF1 STAT1 AGO3 SACS ANKIB1 DMD FASTKD3 DNA2 NAA15 NRAS RBM4 IARS1 DDX60 TOR1A CCNA2 CASK ABCE1 CCNE2 PRIM2 PAXIP1 CHEK2 UHRF1 ATF4 CDC25A EDRF1 | 1.93e-05 | 1407 | 243 | 30 | M14427 |
| Coexpression | SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM | 1.96e-05 | 36 | 243 | 5 | M16679 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | ABCA1 ADAM9 ADGRV1 CMYA5 RFTN1 RAB9A PIK3C2B MME GOLGA4 ANK3 DDX60 NBEA TGFBR2 ARHGAP5 AASS ZNF654 | 2.16e-05 | 504 | 243 | 16 | M2157 |
| Coexpression | SENESE_HDAC1_TARGETS_UP | ABCC4 SUPT6H VKORC1L1 C3 NSMAF VEGFA RB1 DOCK10 CHST11 TGFBR2 ARHGAP5 PDE12 CCNE2 PRIM2 SERPINB2 | 2.29e-05 | 451 | 243 | 15 | M14973 |
| Coexpression | ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP | HSP90B1 UAP1 DAB1 ZBTB41 JMY SACS UQCRB GOLGA4 RAP1B NAA15 NRAS ANK3 DDX60 DOCK10 ARFGEF2 RANBP6 ARHGAP5 ABCE1 EDRF1 | 2.49e-05 | 687 | 243 | 19 | M41022 |
| Coexpression | SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE | 3.71e-05 | 67 | 243 | 6 | M12037 | |
| Coexpression | REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS | 4.26e-05 | 8 | 243 | 3 | M679 | |
| Coexpression | RIGGINS_TAMOXIFEN_RESISTANCE_DN | 4.41e-05 | 221 | 243 | 10 | M15835 | |
| Coexpression | GOZGIT_ESR1_TARGETS_DN | NUP210L PDK3 MPDZ STAT1 CFB RFTN1 PTPN13 NECTIN2 UGCG PLCB1 KDR CMAHP UTRN ANK3 NBEA CASK LPIN2 IFT122 LSM14B GABBR1 | 4.90e-05 | 786 | 243 | 20 | M10961 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | ILDR2 TMC7 ADAM9 ASH1L PFKFB3 STAT1 SCD RAB3GAP2 GMDS SHE MME NSMAF VEGFA GPD2 RAP1A RAP1B PON2 AP4E1 TGFBR2 ARHGAP5 LPIN2 | 5.17e-05 | 854 | 243 | 21 | M1533 |
| Coexpression | WANG_LSD1_TARGETS_DN | 5.93e-05 | 45 | 243 | 5 | MM740 | |
| Coexpression | AFFAR_YY1_TARGETS_DN | SETD1A MCM7 TTF1 SCD FDPS PLCB1 RAB27A PCDHB12 PCDHB11 CCNA2 UHRF1 | 7.30e-05 | 283 | 243 | 11 | MM1157 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL | ILDR2 PGAM5 SACS SCD PYGL DNA2 TTI2 FREM3 CCNA2 SH3PXD2B CCNE2 PRIM2 CHEK2 UHRF1 CDC25A CDC25B | 8.71e-05 | 567 | 243 | 16 | M45692 |
| Coexpression | GSE24574_BCL6_LOW_TFH_VS_TCONV_CD4_TCELL_UP | 8.77e-05 | 194 | 243 | 9 | M8340 | |
| Coexpression | GABRIELY_MIR21_TARGETS | SMC1A MPDZ RAB3GAP2 DMD UTRN GOLGA4 GPD2 DOCK10 NBEA TGFBR2 CDC25A | 8.80e-05 | 289 | 243 | 11 | M2196 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | ILDR2 TMC7 ADAM9 ASH1L PFKFB3 STAT1 SCD RAB3GAP2 GMDS SHE MME NSMAF VEGFA GPD2 RAP1A RAP1B PON2 AP4E1 TGFBR2 ARHGAP5 LPIN2 | 8.96e-05 | 888 | 243 | 21 | MM1018 |
| Coexpression | DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY | 9.18e-05 | 26 | 243 | 4 | M16488 | |
| Coexpression | NUYTTEN_EZH2_TARGETS_UP | HSP90B1 UAP1 ABCA13 NT5C3A KCTD1 PFKFB2 STAT1 TPCN1 RFTN1 PIK3CB NR3C2 VEGFA MRAS IARS1 DDX60 PON2 TGFBR2 EFNA5 RNF2 SERPINB2 MARVELD2 MAPK6 ZNF654 | 1.02e-04 | 1033 | 243 | 23 | M4196 |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_DN | 1.02e-04 | 198 | 243 | 9 | M8274 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_DN | ABCC4 DCAF6 UAP1 TRO TM6SF1 RTN1 STAT1 ME3 SACS CCNA1 PLCB1 SYN1 SYN2 DMD DYNC1H1 VEGFA ANK3 IARS1 ARFGEF2 TOR1A PON2 ACTR1A ABCE1 SEC23IP FBXO21 GABBR1 | 1.05e-04 | 1248 | 243 | 26 | M17728 |
| Coexpression | GSE18281_CORTICAL_VS_MEDULLARY_THYMOCYTE_UP | 1.07e-04 | 199 | 243 | 9 | M7252 | |
| Coexpression | GSE22033_UNTREATED_VS_ROSIGLITAZONE_TREATED_MEF_DN | 1.07e-04 | 199 | 243 | 9 | M7690 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_UP | 1.07e-04 | 199 | 243 | 9 | M7712 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_DN | 1.07e-04 | 199 | 243 | 9 | M5151 | |
| Coexpression | GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UP | 1.07e-04 | 199 | 243 | 9 | M7821 | |
| Coexpression | SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE | 1.08e-04 | 81 | 243 | 6 | M11189 | |
| Coexpression | GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_DN | HSP90B1 ADAM9 VKORC1L1 NAALAD2 ARHGAP5 TIAM1 CCNE2 LPIN2 CRYBG3 | 1.11e-04 | 200 | 243 | 9 | M7196 |
| Coexpression | GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_UP | NT5C3A SEPTIN8 MAGED2 ANKIB1 UTRN RAP1B RANBP6 NBEA MARVELD2 | 1.11e-04 | 200 | 243 | 9 | M7489 |
| Coexpression | GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN | 1.11e-04 | 200 | 243 | 9 | M6193 | |
| Coexpression | GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_DN | 1.11e-04 | 200 | 243 | 9 | M5130 | |
| Coexpression | GSE17721_0.5H_VS_4H_POLYIC_BMDC_DN | 1.11e-04 | 200 | 243 | 9 | M4091 | |
| Coexpression | GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_DN | 1.11e-04 | 200 | 243 | 9 | M4459 | |
| Coexpression | GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 1.11e-04 | 200 | 243 | 9 | M6993 | |
| Coexpression | GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_UP | 1.47e-04 | 163 | 243 | 8 | M8663 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_CYCLING_DC_CELL | UAP1 NT5C3A IRF4 MCM7 UPF3B TTF1 SACS SEL1L3 HRAS GMDS DNA2 TBP USP13 NAA15 USB1 IARS1 TOR1A CCNA2 GTF2H2 PDE12 POLR1E CCNE2 CFAP20 PRIM2 CHEK2 UHRF1 SEPTIN11 CDC25B | 1.47e-04 | 1423 | 243 | 28 | M45722 |
| Coexpression | COLDREN_GEFITINIB_RESISTANCE_UP | 1.51e-04 | 86 | 243 | 6 | M18134 | |
| Coexpression | AFFAR_YY1_TARGETS_DN | 1.69e-04 | 260 | 243 | 10 | M1471 | |
| Coexpression | LY_AGING_OLD_DN | 1.71e-04 | 56 | 243 | 5 | M18789 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 1.72e-04 | 212 | 243 | 9 | M39221 | |
| Coexpression | CARRILLOREIXACH_MRS3_VS_LOWER_RISK_HEPATOBLASTOMA_DN | 1.81e-04 | 168 | 243 | 8 | M45039 | |
| Coexpression | SRC_UP.V1_DN | 1.96e-04 | 170 | 243 | 8 | M2713 | |
| Coexpression | ZHENG_IL22_SIGNALING_UP | 2.02e-04 | 58 | 243 | 5 | M1800 | |
| Coexpression | CAFFAREL_RESPONSE_TO_THC_DN | 2.11e-04 | 32 | 243 | 4 | M17998 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | ACLY ASH1L PFKFB2 SCD PLCB1 UTRN DYNC1H1 GOLGA4 VEGFA ERO1B DOCK10 ARFGEF2 NBEA NR3C1 PRPF8 ARHGAP5 EFNA5 RNF2 TIAM1 VPS35 GIGYF2 | 2.13e-04 | 946 | 243 | 21 | M39169 |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | UAP1 TRO PFKFB3 PTPN13 SUPT6H NECTIN2 HRAS PLCB1 DMD GOLGA4 ANK3 GDPD3 ECE1 VIRMA ABCE1 CHEK2 | 2.20e-04 | 615 | 243 | 16 | M8673 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | ABCA1 PDK3 JMY MME GOLGA4 NSMAF VEGFA USP36 KRAS ERO1B CHST11 VIRMA PDE12 CFAP20 GIGYF2 FBXO21 EDRF1 | 2.23e-04 | 680 | 243 | 17 | M41089 |
| Coexpression | VILLANUEVA_LIVER_CANCER_KRT19_UP | 2.39e-04 | 175 | 243 | 8 | M336 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | NT5C3A IRF4 SCN8A TMEM252 CMAHP UTRN NSMAF GPD2 RAP1A RB1 DOCK10 TGFBR2 ARHGAP5 DYNLT5 | 2.50e-04 | 498 | 243 | 14 | M1741 |
| Coexpression | PILON_KLF1_TARGETS_UP | ABCA1 TMC7 NT5C3A CFB CSNK1G1 KMT2A PMM2 ANK3 PON2 CRX GTF2H2 DENND2C LPIN2 GIGYF2 | 2.76e-04 | 503 | 243 | 14 | M2226 |
| Coexpression | CHICAS_RB1_TARGETS_SENESCENT | SMC1A MCM7 TM6SF1 SEL1L3 C3 RAB27A DYNC1H1 VEGFA GPD2 KRAS DDX60 CCNE2 UHRF1 CDC25A FBXO21 | 2.78e-04 | 565 | 243 | 15 | M2125 |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | ACLY SMC1A IRF4 MCM7 TTF1 FDPS DNA2 TBP KRAS USP13 RB1 IARS1 CCNA2 RNF2 ABCE1 CCNE2 PAXIP1 CHEK2 | 2.86e-04 | 761 | 243 | 18 | M11961 |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | NT5C3A IRF4 SCN8A TMEM252 CMAHP UTRN NSMAF GPD2 RAP1A RB1 DOCK10 TGFBR2 ARHGAP5 DYNLT5 | 2.99e-04 | 507 | 243 | 14 | MM1030 |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_DN | 3.00e-04 | 181 | 243 | 8 | M8889 | |
| Coexpression | ACEVEDO_LIVER_CANCER_UP | UAP1 ACLY TRAPPC4 UQCRB GOLGA4 USP13 NRAS ARV1 USB1 UFC1 DOCK10 PON2 RANBP6 CCNA2 CASK NBAS PDE12 VPS35 SEC23IP SEPTIN11 MARVELD2 | 3.06e-04 | 972 | 243 | 21 | M15709 |
| Coexpression | HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN | 3.23e-04 | 282 | 243 | 10 | M7623 | |
| Coexpression | DESCARTES_MAIN_FETAL_PHOTORECEPTOR_CELLS | 3.63e-04 | 101 | 243 | 6 | M40100 | |
| Coexpression | PUJANA_BREAST_CANCER_LIT_INT_NETWORK | 3.63e-04 | 101 | 243 | 6 | M15356 | |
| Coexpression | SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6 | MYO7A SCD PYGL DNA2 VEGFA ATG5 GPD2 NRAS ARFGEF2 CCNA2 CCNE2 PRIM2 CDC25A | 3.78e-04 | 458 | 243 | 13 | M8520 |
| Coexpression | PDGF_UP.V1_UP | 4.39e-04 | 146 | 243 | 7 | M2834 | |
| Coexpression | WEI_MYCN_TARGETS_WITH_E_BOX | ABCC4 UAP1 ACLY SMC1A APTX HRAS PLCB1 PMM2 DNTT GPD2 NAA15 RB1 ABCE1 CCNE2 CFAP20 PRIM2 UHRF1 CDC25A | 4.60e-04 | 792 | 243 | 18 | M12113 |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | UAP1 TRO PFKFB3 PTPN13 SUPT6H NECTIN2 HRAS PLCB1 DMD GOLGA4 ANK3 GDPD3 ECE1 VIRMA ABCE1 CHEK2 | 4.69e-04 | 659 | 243 | 16 | MM1040 |
| Coexpression | GSE10325_BCELL_VS_LUPUS_BCELL_UP | 4.77e-04 | 194 | 243 | 8 | M3094 | |
| Coexpression | GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_UP | 4.93e-04 | 195 | 243 | 8 | M9527 | |
| Coexpression | GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN | 4.93e-04 | 195 | 243 | 8 | M5353 | |
| Coexpression | BENPORATH_ES_2 | 5.07e-04 | 40 | 243 | 4 | M4241 | |
| Coexpression | GSE3982_BCELL_VS_NKCELL_DN | 5.28e-04 | 197 | 243 | 8 | M5548 | |
| Coexpression | GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_DN | 5.45e-04 | 198 | 243 | 8 | M3242 | |
| Coexpression | GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_UP | 5.45e-04 | 198 | 243 | 8 | M4704 | |
| Coexpression | GSE26343_UNSTIM_VS_LPS_STIM_NFAT5_KO_MACROPHAGE_UP | 5.45e-04 | 198 | 243 | 8 | M8649 | |
| Coexpression | GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_UP | 5.45e-04 | 198 | 243 | 8 | M5790 | |
| Coexpression | GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_DN | 5.64e-04 | 199 | 243 | 8 | M3311 | |
| Coexpression | GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_UP | 5.64e-04 | 199 | 243 | 8 | M3337 | |
| Coexpression | GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_UP | 5.64e-04 | 199 | 243 | 8 | M8277 | |
| Coexpression | GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP | 5.64e-04 | 199 | 243 | 8 | M8619 | |
| Coexpression | GSE44649_WT_VS_MIR155_KO_ACTIVATED_CD8_TCELL_UP | 5.64e-04 | 199 | 243 | 8 | M9782 | |
| Coexpression | GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_DN | 5.64e-04 | 199 | 243 | 8 | M7479 | |
| Coexpression | GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN | 5.64e-04 | 199 | 243 | 8 | M7524 | |
| Coexpression | GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP | 5.64e-04 | 199 | 243 | 8 | M6040 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP | 5.64e-04 | 199 | 243 | 8 | M7420 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA1 ACLY ASH1L PFKFB2 KMT2A DYNC1H1 GOLGA4 VEGFA GPD2 ERO1B COL6A6 NSD1 NBEA | 6.36e-11 | 195 | 243 | 13 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA1 ACLY ASH1L PFKFB2 KMT2A DYNC1H1 GOLGA4 VEGFA GPD2 ERO1B COL6A6 NBEA | 8.78e-10 | 195 | 243 | 12 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NUP210L SMC1A ASH1L STAT1 KDR NR3C2 UTRN NSD1 NR3C1 ARHGAP5 ZBED6 | 4.28e-09 | 178 | 243 | 11 | 01dafd19de04eff459253eaa9a35debf8f3deedf |
| ToppCell | Tuft-tuft-1|World / Class top | 3.13e-08 | 168 | 243 | 10 | 8ddc2ec483ed2c6c0fb2ae521c6861ceb6d32e34 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 9.03e-08 | 188 | 243 | 10 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | CPPED1 PFKFB3 SEMA4C VEGFA NAA15 ERO1B USB1 RB1 DOCK10 CCNE2 | 1.53e-07 | 199 | 243 | 10 | bbb4798d6a24e756fea744a151ba67c1bafbac9a |
| ToppCell | severe-immature_Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | ABCA13 PFKFB2 SCD UGCG PYGL RAB27A CCNA2 CCNE2 DENND2C DYNLT5 | 1.61e-07 | 200 | 243 | 10 | 5ee43386da8261d2e7602a152e6ba4338d844e08 |
| ToppCell | severe-immature_Neutrophil|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | ABCA13 PFKFB2 SCD UGCG SCN9A PYGL RAB27A DENND2C DYNLT5 GABBR1 | 1.61e-07 | 200 | 243 | 10 | a9b87accdaa6956116ab82427e1330e8f007ef94 |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-07 | 178 | 243 | 9 | de6cd81e6d58e7687386df163471bf1901b9c0aa | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 9.28e-07 | 187 | 243 | 9 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.21e-06 | 193 | 243 | 9 | c2673d86f7d7b849788036032a93a6d136a70040 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | SMC1A ZBTB41 ADGRV1 UTRN DYNC1H1 ZBED6 GIGYF2 MARVELD2 CRYBG3 | 1.21e-06 | 193 | 243 | 9 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-06 | 194 | 243 | 9 | 92b39a935e8c577eb1123d706d168fa13cf3344c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 195 | 243 | 9 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.49e-06 | 198 | 243 | 9 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | mild-CD4+_Tcm|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.55e-06 | 199 | 243 | 9 | 06c8a0e39f7a33736548f04a5e2263334c8541cf | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.62e-06 | 200 | 243 | 9 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-immature_Neutrophil|COVID-19_Severe / Disease, condition lineage and cell class | 1.62e-06 | 200 | 243 | 9 | cbe667eda1af222467df8bfa157aa22df488f133 | |
| ToppCell | LPS-antiTNF-Endothelial-Mes-Like-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.73e-06 | 166 | 243 | 8 | 3b750d4023a0a09d86113aae5a97d84391f7b482 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.51e-06 | 175 | 243 | 8 | 77c16e615c0fb9c83f29d7e0a547be72635fac81 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-06 | 175 | 243 | 8 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-06 | 176 | 243 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 6.51e-06 | 179 | 243 | 8 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-06 | 181 | 243 | 8 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.06e-06 | 181 | 243 | 8 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-06 | 183 | 243 | 8 | 42dc31d587fbb9724b2f0be5ee8ed77233f67b86 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.28e-06 | 185 | 243 | 8 | a8946379fc066903fe8f4bc9cbf693b7b424a0cd | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.62e-06 | 186 | 243 | 8 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 9.32e-06 | 188 | 243 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-05 | 190 | 243 | 8 | 23f2ac4da431211084bb6ab0494c2e0b69547cb6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-05 | 190 | 243 | 8 | 3c337374d89e69cc0a78e65a4a7e21db7b050fcd | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.05e-05 | 191 | 243 | 8 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | IPF-Epithelial-Goblet|Epithelial / Disease state, Lineage and Cell class | 1.05e-05 | 191 | 243 | 8 | 267e1192aaec468c1a59eb24848b37e0e18cbc44 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 192 | 243 | 8 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-05 | 192 | 243 | 8 | aedddccacf60e884af044cefba6c64ca10ac97d2 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-05 | 192 | 243 | 8 | 389d5e6d0689371bfe1d0b06e92e0e6e5573567b | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 192 | 243 | 8 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | ILEUM-non-inflamed-(1)_Th17_Trm|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.09e-05 | 192 | 243 | 8 | 7347ff4dedd1aaa489c4f15e5ae647a4ce39ac72 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.13e-05 | 193 | 243 | 8 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Control-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 1.13e-05 | 193 | 243 | 8 | 4cb938c346cc32ec122d11e6b9f25db20e0f7ff6 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.17e-05 | 194 | 243 | 8 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | control-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.22e-05 | 195 | 243 | 8 | bfaceb0601cf3855f38d6e1f482f01ad03ef11fe | |
| ToppCell | Secretory|World / shred by cell class for bronchial biopsy | 1.22e-05 | 195 | 243 | 8 | 52f8281fe0df67cec3faa780a23ed6343ed5a6ba | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.22e-05 | 195 | 243 | 8 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.26e-05 | 196 | 243 | 8 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | IPF-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 1.26e-05 | 196 | 243 | 8 | 6e70c48a63d9673eb16b0847c1bd88eecc2f7a3c | |
| ToppCell | COPD-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 1.26e-05 | 196 | 243 | 8 | c9bdd505c3ab380ed7b272aa518df31a0a706a06 | |
| ToppCell | severe-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.31e-05 | 197 | 243 | 8 | 70704b149b2820b8601d2495b7cd9cbe91eda262 | |
| ToppCell | ASK440-Epithelial-Type_2|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.31e-05 | 197 | 243 | 8 | 08d5bbeb77a4152af1c783bc958afcae24667767 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-05 | 197 | 243 | 8 | 8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.31e-05 | 197 | 243 | 8 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | normal_Lung-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 1.36e-05 | 198 | 243 | 8 | fbd72ebaba73cc30e79dc8a8c3d46b6f863c1494 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 1.36e-05 | 198 | 243 | 8 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.36e-05 | 198 | 243 | 8 | e0df6d6ff2a9c41d813f84a2a5ee7cb5f6fc3e30 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-05 | 198 | 243 | 8 | b027a141ab531d0f5d6a26811a53427e7b0771dd | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-05 | 198 | 243 | 8 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-05 | 198 | 243 | 8 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-05 | 198 | 243 | 8 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.36e-05 | 198 | 243 | 8 | 844f534551483c89ef789d1cfeb4680e54f794b2 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-05 | 198 | 243 | 8 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.36e-05 | 198 | 243 | 8 | 0cd930e374c2c48d1991b51c025f9801b22ecee7 | |
| ToppCell | Caecum-T_cell-Activated_CD4_T|T_cell / Region, Cell class and subclass | 1.41e-05 | 199 | 243 | 8 | 13173cc4dcc8e856680372b0a4ad4f36afa892c1 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.41e-05 | 199 | 243 | 8 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.41e-05 | 199 | 243 | 8 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Goblet_3|World / shred by cell class for nasal brushing | 1.41e-05 | 199 | 243 | 8 | 4229a17a3a6d8855655acc0a1c8704166f8e74c0 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Club|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.46e-05 | 200 | 243 | 8 | 292c63693eb7f435335a8cfba07aa35b72139393 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.46e-05 | 200 | 243 | 8 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.46e-05 | 200 | 243 | 8 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.46e-05 | 200 | 243 | 8 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.46e-05 | 200 | 243 | 8 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.46e-05 | 200 | 243 | 8 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.46e-05 | 200 | 243 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.46e-05 | 200 | 243 | 8 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.32e-05 | 155 | 243 | 7 | d76a0f99ec35560d18820f9c92b69364ef2250e3 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 158 | 243 | 7 | 12661763d1c309106801cb710c04cd2b62d16cba | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 158 | 243 | 7 | 0792c39e6fc0745095af7812de2d50949540d60f | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 158 | 243 | 7 | e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72 | |
| ToppCell | COPD-Myeloid-DC_Langerhans|COPD / Disease state, Lineage and Cell class | 2.62e-05 | 158 | 243 | 7 | 71af1319eec34bf7bc9361ec9ef720c280ce97d1 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.08e-05 | 162 | 243 | 7 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-05 | 162 | 243 | 7 | b502d6af6868425b5c919740e011330c0d3cf3b8 | |
| ToppCell | COPD-Myeloid-DC_Langerhans|Myeloid / Disease state, Lineage and Cell class | 3.33e-05 | 164 | 243 | 7 | a07c6e13c07a90bc37db0915eb14931eb8309a1e | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.33e-05 | 164 | 243 | 7 | 5621c2e3fae84d5a2e4f1595e454bcb3a2b3f93c | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP3_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.03e-05 | 169 | 243 | 7 | d9c3b22f62b882b8a2ea6fd9cf7afbe6d1775745 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-05 | 169 | 243 | 7 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.35e-05 | 171 | 243 | 7 | 4fd2c7977c512c51507f055fc74b111c0228ed8b | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 4.35e-05 | 171 | 243 | 7 | adbcfa4bf6bc1c604535a24435924cdb091e2dd7 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-05 | 172 | 243 | 7 | 2f1673fcb2356684d60871debb0f159aec553a1c | |
| ToppCell | droplet-Spleen-SPLEEN|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-05 | 172 | 243 | 7 | d32731a56e113ff0ef7167b23959d69baf2068f9 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-05 | 172 | 243 | 7 | b3c4adccc34bb9e4e78e40f4e2e23736c347cc75 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.85e-05 | 174 | 243 | 7 | 5f4436863a40f8bca46e2989bca66c02b6be88d4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-05 | 175 | 243 | 7 | 98947a226b5a2ac7091ff9d34243ea7736add973 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.22e-05 | 176 | 243 | 7 | 25ebc8716aa44e44fce577701e3e82c6745a75ab | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 5.22e-05 | 176 | 243 | 7 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.22e-05 | 176 | 243 | 7 | 792f414f5092aba14260b8e16378e793a822498e | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.41e-05 | 177 | 243 | 7 | 8887ff6341eb070bdaa890cc2cd7745f0cf1b0af | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-CD45____plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-05 | 177 | 243 | 7 | f0487e3b439f7803e465cad44916e2e271f33d6d | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.41e-05 | 177 | 243 | 7 | 59726bfd98f656fdcedf448a7e2e76a9bfad8285 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.41e-05 | 177 | 243 | 7 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.41e-05 | 177 | 243 | 7 | 507f06d31ab773099c9431b6f433899dc97b5566 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.60e-05 | 178 | 243 | 7 | ad3de3e03a401dac64431a541899445262246347 | |
| Computational | Genes in the cancer module 57. | 1.80e-06 | 56 | 163 | 8 | MODULE_57 | |
| Drug | Ampyrone [83-07-8]; Up 200; 19.6uM; PC3; HT_HG-U133A | ABCA1 SMC1A STAT1 KMT2A NR3C2 GPD2 RBM4 GDPD3 CASK RNF2 TIAM1 SEPTIN11 FBXO21 | 2.03e-07 | 196 | 243 | 13 | 2086_UP |
| Drug | Ethylnitrosourea | PDE6B MYO7A ADGRV1 FREM1 STAT1 UGCG SCN8A HRAS KDR DMD DYNC1H1 KRAS RB1 CHEK2 MAPK6 | 6.11e-07 | 291 | 243 | 15 | ctd:D005038 |
| Drug | valrocemide | 8.57e-07 | 8 | 243 | 4 | CID006918293 | |
| Drug | Fenofibrate [49562-28-9]; Up 200; 11uM; MCF7; HT_HG-U133A | ABCC4 SEL1L3 PLCB1 KMT2A RAB27A VEGFA ATG5 USB1 MBOAT7 NR3C1 CDC25A EDRF1 | 1.40e-06 | 196 | 243 | 12 | 7432_UP |
| Drug | Fusaric acid [536-69-6]; Down 200; 22.4uM; PC3; HT_HG-U133A | SMC1A ASH1L RAB3GAP2 CSNK1G1 SYN2 TTLL1 VEGFA ERO1B FRMPD1 SMG5 TGFBR2 LSM14B | 1.56e-06 | 198 | 243 | 12 | 3986_DN |
| Drug | austenitic steel | 2.53e-06 | 10 | 243 | 4 | ctd:C426023 | |
| Drug | Acetylcysteine | HSP90B1 PDE6B SMC1A STAT1 KCNQ5 HRAS CCNA1 SYN1 PYGL C3 KDR NR3C2 VEGFA ATG5 KRAS RB1 PON2 NR3C1 CCNA2 TGFBR2 CCNE2 CHEK2 UHRF1 ATF4 | 3.63e-06 | 780 | 243 | 24 | ctd:D000111 |
| Drug | troglitazone | ABCA1 TRO NT5C3A PFKFB2 PFKFB3 STAT1 TPCN1 PIK3C2B PIK3CB SCD CCNA1 VEGFA GPD2 RB1 PON2 NR3C1 CCNA2 CCNE2 MAPK6 | 4.18e-06 | 526 | 243 | 19 | CID000005591 |
| Drug | torcetrapib | SMC1A CSNK1G1 KMT2A NR3C2 DYNC1H1 MRAS NAA15 ANK3 NR3C1 ECE1 CASK TGFBR2 SEPTIN11 LSM14B EDRF1 | 4.50e-06 | 342 | 243 | 15 | ctd:C483909 |
| Drug | L 744832 | 4.77e-06 | 4 | 243 | 3 | ctd:C096898 | |
| Drug | adenosine 3',5'-cyclic phosphate | KCNH8 PDE6B INPP5D NT5C3A PFKFB2 PFKFB3 PHKA1 CSNK1G1 HRAS PLCB1 SYN1 SYN2 KCNQ3 PYGL DMD VEGFA DNTT RAP1A RAP1B NR3C1 ACTR1A GUCY2C KCNQ4 LPIN2 ATF4 MAPK6 | 5.02e-06 | 907 | 243 | 26 | CID000000274 |
| Drug | Hesperetin [520-33-2]; Down 200; 13.2uM; PC3; HT_HG-U133A | HSP90B1 STAT1 PIK3CB UTRN ARFGEF2 NR3C1 PDE12 CCNE2 SEC23IP SEPTIN11 CDC25A | 6.31e-06 | 189 | 243 | 11 | 6750_DN |
| Drug | UCN-01 | 6.38e-06 | 154 | 243 | 10 | CID000072271 | |
| Drug | Alexidine dihydrochloride [22573-93-9]; Down 200; 6.8uM; PC3; HT_HG-U133A | KMT2B PDK3 TTF1 PIK3C2B DNA2 RAB27A DOCK10 TOR1A RANBP6 CCNE2 SEC23IP | 6.97e-06 | 191 | 243 | 11 | 7397_DN |
| Drug | Guanosine-5'-Diphosphate | 8.39e-06 | 13 | 243 | 4 | DB04315 | |
| Drug | Glucose | HSP90B1 ACLY AZGP1 UPF3B STAT1 SLC13A4 SCD RAB3GAP2 HRAS PLCB1 PYGL C3 KDR MME DNA2 GOLGA4 VEGFA USP36 GPD2 RAP1A RAP1B MRAS NAA15 NRAS PON2 NBEA RPSA NR3C1 TGFBR2 RNF2 PRIM2 SEPTIN11 ATF4 CDC25A | 8.48e-06 | 1420 | 243 | 34 | ctd:D005947 |
| Drug | Paclitaxel [33069-62-4]; Down 200; 4.6uM; MCF7; HT_HG-U133A | TMC7 STAT1 RFTN1 SGPL1 RAB27A ATG7 NR3C1 CASK NBAS CCNE2 SEC23IP | 9.35e-06 | 197 | 243 | 11 | 5320_DN |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; HL60; HT_HG-U133A | 9.81e-06 | 198 | 243 | 11 | 2700_DN | |
| Drug | Proparacaine hydrochloride [5875-06-9]; Up 200; 12uM; MCF7; HT_HG-U133A | SETD1B PDE6B MYO7A SCN10A C3 NAALAD2 ERO1B DDX60 FRMPD1 AASS SEPTIN11 | 1.03e-05 | 199 | 243 | 11 | 5433_UP |
| Drug | Levodopa [59-92-7]; Down 200; 20.2uM; HL60; HG-U133A | ADAM9 PFKFB3 PIK3C2B UQCRB FASTKD3 KRAS RAP1A USB1 NR3C1 CASK OSTF1 | 1.03e-05 | 199 | 243 | 11 | 1972_DN |
| Drug | 2,3,5-trichloro-6-phenyl-(1,4)benzoquinone | 1.07e-05 | 28 | 243 | 5 | ctd:C587734 | |
| Drug | Quinazolinones | 1.18e-05 | 5 | 243 | 3 | ctd:D052999 | |
| Drug | AC1L1IHP | PHKA1 PTPN13 PIK3CB CSNK1G1 CCNA1 SYN2 PYGL UTRN VEGFA RB1 COG7 NR3C1 CCNA2 ACTR1A POLR1E ABCE1 SERPINB2 CHEK2 UHRF1 MAPK6 CDC25A CDC25B | 1.24e-05 | 728 | 243 | 22 | CID000004584 |
| Drug | Lithium Chloride | MCM7 RTN1 MAGED2 UGCG SCN9A CCNA1 KDR VEGFA RB1 CCNA2 TGFBR2 CCNE2 ATF4 MARVELD2 | 1.28e-05 | 328 | 243 | 14 | ctd:D018021 |
| Drug | Zinc Sulfate | IRF4 PFKFB2 PFKFB3 STAT1 CHRNB4 SEPTIN8 UGCG ANKIB1 CCNA1 C3 KDR DYNC1H1 NSMAF VEGFA TBPL2 MRAS RB1 NR3C1 LRRC9 SH3PXD2B LPIN2 SEPTIN11 | 1.57e-05 | 739 | 243 | 22 | ctd:D019287 |
| Drug | triptolide | 1.68e-05 | 172 | 243 | 10 | ctd:C001899 | |
| Drug | Mustard Gas | SETD1A SETD1B TRO ETV4 PFKFB2 TTF1 STAT1 CFB KCNU1 CCNA1 PLCB1 C3 KDR MME DMD VEGFA DNTT GPD2 MRAS RB1 GDPD3 NSD1 CCNA2 CASK RNF2 SERPINB2 CHEK2 UHRF1 GIGYF2 ATF4 CDC25A CDC25B | 1.72e-05 | 1341 | 243 | 32 | ctd:D009151 |
| Drug | geranylgeranyl pyrophosphate | 1.90e-05 | 139 | 243 | 9 | CID000000735 | |
| Drug | methylseleninic acid | 2.01e-05 | 78 | 243 | 7 | CID000161597 | |
| Drug | NSC60597 | 2.02e-05 | 140 | 243 | 9 | CID000003327 | |
| Drug | isosilybin B | 2.11e-05 | 32 | 243 | 5 | CID003085830 | |
| Drug | 17-AAG; Up 200; 1uM; HL60; HT_HG-U133A | HSP90B1 TRO SMC1A SGPL1 NAALAD2 ANK3 MBOAT7 TIAM1 AASS PCNX4 | 2.27e-05 | 178 | 243 | 10 | 2685_UP |
| Drug | N-(1-(3-morpholin-4-ylphenyl)ethyl)-3-phenylacrylamide | 2.35e-05 | 6 | 243 | 3 | ctd:C476437 | |
| Drug | diarsenic | 2.35e-05 | 6 | 243 | 3 | CID006398629 | |
| Drug | Mifepristone | ABCA1 ACLY CFB HRAS C3 KDR NR3C2 UQCRB VEGFA RAP1A RAP1B RB1 NR3C1 CCNA2 KMT2D SEC23IP MAPK6 CDC25B | 3.02e-05 | 553 | 243 | 18 | ctd:D015735 |
| Drug | AC1L73CW | 3.26e-05 | 84 | 243 | 7 | CID000328776 | |
| Drug | methylselenic acid | HSP90B1 ABCC4 MCM7 SCD UTRN ANK3 RB1 RPSA NR3C1 CCNA2 TGFBR2 CCNE2 PAXIP1 CHEK2 CDC25A | 4.01e-05 | 412 | 243 | 15 | ctd:C008493 |
| Drug | Zidovudine | ABCC4 NT5C3A TTC21A IRF4 PFKFB3 STAT1 HRAS UQCRB DMD DNA2 KRAS NR3C1 CCNA2 TRMT44 CCNE2 CHEK2 CDC25A | 4.88e-05 | 521 | 243 | 17 | ctd:D015215 |
| Drug | Tiapride hydrochloride [51012-33-0]; Up 200; 11uM; MCF7; HT_HG-U133A | TM6SF1 RFTN1 RAB27A KRAS FRMPD1 NR3C1 CASK AP4E1 LPIN2 EDRF1 | 4.93e-05 | 195 | 243 | 10 | 4686_UP |
| Drug | Trimeprazine tartrate [4330-99-8]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 4.93e-05 | 195 | 243 | 10 | 3478_UP | |
| Drug | Dehydrocholic acid [81-23-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A | CPPED1 APTX RFTN1 C3 VEGFA ARFGEF2 SMG5 AP4E1 SEPTIN11 EDRF1 | 4.93e-05 | 195 | 243 | 10 | 1523_DN |
| Drug | Suloctidil [54063-56-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 4.93e-05 | 195 | 243 | 10 | 5021_DN | |
| Drug | Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 5.37e-05 | 197 | 243 | 10 | 6776_DN | |
| Drug | Colistin sulfate [1264-72-8]; Down 200; 3uM; PC3; HT_HG-U133A | ABCA1 TBKBP1 ST8SIA5 UTRN KRAS DDX60 FRMPD1 CHST11 ECE1 TIAM1 | 5.37e-05 | 197 | 243 | 10 | 4212_DN |
| Drug | Phenindione [83-12-5]; Down 200; 18uM; MCF7; HT_HG-U133A | 5.37e-05 | 197 | 243 | 10 | 2868_DN | |
| Drug | Dimenhydrinate [523-87-5]; Down 200; 8.6uM; PC3; HT_HG-U133A | ABCA1 APTX TPCN1 SUPT6H CSNK1G1 PLCB1 UTRN MBOAT7 NBAS PDE12 | 5.60e-05 | 198 | 243 | 10 | 6352_DN |
| Drug | Glimepiride [93479-97-1]; Up 200; 8.2uM; HL60; HT_HG-U133A | TMC7 AZGP1 TPCN1 PTPN13 SUPT6H NECTIN2 SCN10A SYN2 ANK3 USB1 | 5.60e-05 | 198 | 243 | 10 | 2154_UP |
| Drug | Dyclonine hydrochloride [536-43-6]; Up 200; 12.2uM; PC3; HT_HG-U133A | CEP104 HSP90B1 KMT2B PDE6B PFKFB2 UGCG DOCK10 SEC23IP SEPTIN11 LSM14B | 5.60e-05 | 198 | 243 | 10 | 7261_UP |
| Drug | Gelsemine [509-15-9]; Up 200; 12.4uM; HL60; HT_HG-U133A | SMC1A SEMA4C SEPTIN8 PTPN13 SCN10A TTLL1 ST8SIA5 NAALAD2 CCNA2 LSM14B | 5.85e-05 | 199 | 243 | 10 | 2162_UP |
| Drug | Lidoflazine [3416-26-0]; Down 200; 8.2uM; PC3; HT_HG-U133A | 5.85e-05 | 199 | 243 | 10 | 5804_DN | |
| Drug | nickel chloride | HSP90B1 ABCA1 ACLY INPP5D AZGP1 PFKFB3 STAT1 RAB9A FDPS UGCG PLCB1 KMT2A PYGL C3 PMM2 VEGFA RB1 PON2 RANBP6 NR3C1 PRPF8 ABCE1 CCNE2 NAT10 CDC25A CDC25B ZNF654 CDH17 | 6.44e-05 | 1178 | 243 | 28 | ctd:C022838 |
| Drug | TPBS | 6.46e-05 | 8 | 243 | 3 | CID000025458 | |
| Drug | ibandronic acid | 6.46e-05 | 8 | 243 | 3 | ctd:C073007 | |
| Drug | isovaleramide | 6.46e-05 | 8 | 243 | 3 | CID000010930 | |
| Drug | eslicarbazepine acetate | 6.46e-05 | 8 | 243 | 3 | CID000179344 | |
| Drug | Bvpam | 6.57e-05 | 21 | 243 | 4 | CID000125185 | |
| Drug | fulvestrant | HSP90B1 ABCC4 STAT1 CCNA1 C3 MME VEGFA RAP1A RB1 ECE1 CCNA2 CCNE2 SERPINB2 CHEK2 ATF4 CDC25B | 7.00e-05 | 484 | 243 | 16 | ctd:C070081 |
| Drug | orthovanadate | ABCC4 ABCA1 PDE6B MYO7A STAT1 PTPN13 PIK3CB PLCB1 PYGL DYNC1H1 PMM2 SEC23IP MAPK6 CDC25A DNAH11 | 7.39e-05 | 435 | 243 | 15 | CID000061672 |
| Drug | Cosopt | KCNH8 ETV4 IRF4 STAT1 MME UTRN DNASE1L2 TBP VEGFA ECE1 TGFBR2 ZMYM1 MAPK6 | 8.29e-05 | 341 | 243 | 13 | CID000003154 |
| Drug | 4-vinyl-1-cyclohexene dioxide | 9.21e-05 | 170 | 243 | 9 | ctd:C012606 | |
| Drug | Methoxychlor | HSP90B1 SMC1A UGCG HRAS CCNA1 C3 KDR RAB27A VEGFA MRAS NRAS ARFGEF2 NR3C1 ECE1 TGFBR2 MAPK6 CDC25B | 9.25e-05 | 549 | 243 | 17 | ctd:D008731 |
| Drug | Fludrocortisone | 9.62e-05 | 9 | 243 | 3 | ctd:D005438 | |
| Drug | 19-noraldosterone | 9.62e-05 | 9 | 243 | 3 | CID000127113 | |
| Drug | AC1L32OA | 9.62e-05 | 9 | 243 | 3 | CID000107745 | |
| Drug | monomethyl phthalate | HSP90B1 ABCC4 ABCA1 INPP5D MCM7 STAT1 TPCN1 RAB9A SGPL1 FDPS SCN8A KMT2A C3 DNTT ARFGEF2 RPSA CHST11 VIRMA ARHGAP5 RNF2 TIAM1 PAXIP1 MAPK6 CDC25A | 9.86e-05 | 957 | 243 | 24 | ctd:C517284 |
| Drug | vinylidene chloride | ABCA1 KCNH8 MYO7A ABCA13 PDK3 PFKFB3 FREM1 ME3 SEPTIN8 PTPN13 SACS UGCG PYGL C3 KDR UQCRB KRAS ANK3 GAL3ST1 DOCK10 NSD1 NBEA CHST11 CCNA2 SH3PXD2B GTF2H2 EFNA5 AASS UHRF1 GIGYF2 CDC25B FBXO21 | 1.06e-04 | 1475 | 243 | 32 | ctd:C029297 |
| Drug | fludarabine | 1.11e-04 | 71 | 243 | 6 | ctd:C024352 | |
| Drug | Flumethasone | 1.13e-04 | 2 | 243 | 2 | ctd:D005443 | |
| Drug | CGS 26303 | 1.13e-04 | 2 | 243 | 2 | ctd:C089987 | |
| Drug | uranyl phosphate | 1.13e-04 | 2 | 243 | 2 | CID000159848 | |
| Drug | ADR-033 | 1.13e-04 | 2 | 243 | 2 | CID000005586 | |
| Drug | isoprene | 1.13e-04 | 2 | 243 | 2 | ctd:C005059 | |
| Drug | H-gpt-1 | 1.13e-04 | 2 | 243 | 2 | CID000190908 | |
| Drug | mercaptosilane | 1.13e-04 | 2 | 243 | 2 | CID000139670 | |
| Drug | CGS 34043 | 1.13e-04 | 2 | 243 | 2 | ctd:C404931 | |
| Drug | CGS 35066 | 1.13e-04 | 2 | 243 | 2 | ctd:C404932 | |
| Drug | prednylidene | 1.13e-04 | 2 | 243 | 2 | ctd:C036266 | |
| Drug | Hexane-1,6-Diol | 1.13e-04 | 2 | 243 | 2 | DB02210 | |
| Drug | 1,1,3-tribromopropane | 1.13e-04 | 2 | 243 | 2 | CID000134838 | |
| Drug | AC1L4S0Z | 1.13e-04 | 2 | 243 | 2 | CID000191181 | |
| Drug | ABT-100 | 1.14e-04 | 24 | 243 | 4 | CID006451154 | |
| Drug | aurapten | 1.14e-04 | 24 | 243 | 4 | ctd:C105832 | |
| Drug | nimbolide | 1.36e-04 | 10 | 243 | 3 | CID000100017 | |
| Drug | R5-A | 1.36e-04 | 10 | 243 | 3 | CID016058672 | |
| Drug | Guanosine Diphosphate | 1.36e-04 | 10 | 243 | 3 | ctd:D006153 | |
| Drug | AC1LA234 | 1.36e-04 | 10 | 243 | 3 | CID000480136 | |
| Drug | CoCl2 | 1.51e-04 | 75 | 243 | 6 | CID003015678 | |
| Drug | LG 100268 | 1.57e-04 | 26 | 243 | 4 | ctd:C095104 | |
| Drug | testosterone enanthate | CEP104 HSP90B1 MPDZ STAT1 AGO3 SCD UGCG SEL1L3 KMT2A RAB27A GOLGA4 KRAS NAA15 ANK3 CCNE2 SEC23IP ZMYM1 | 1.61e-04 | 575 | 243 | 17 | ctd:C004648 |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Up 200; 10.4uM; PC3; HT_HG-U133A | 1.68e-04 | 184 | 243 | 9 | 7295_UP | |
| Drug | 3,4,3',4'-tetrachloroazobenzene | 1.86e-04 | 11 | 243 | 3 | ctd:C013279 | |
| Drug | AC1L3ULO | 1.86e-04 | 11 | 243 | 3 | CID000095563 | |
| Drug | NSC 663284 | 1.86e-04 | 11 | 243 | 3 | CID000379077 | |
| Drug | Cantharidin [56-25-7]; Down 200; 20.4uM; HL60; HT_HG-U133A | 1.89e-04 | 187 | 243 | 9 | 3075_DN | |
| Drug | silydianin | 2.12e-04 | 28 | 243 | 4 | CID003033957 | |
| Drug | Mefloquine hydrochloride [51773-92-3]; Down 200; 9.6uM; PC3; HT_HG-U133A | 2.22e-04 | 191 | 243 | 9 | 2048_DN | |
| Drug | Proglumide [6620-60-6]; Up 200; 12uM; MCF7; HT_HG-U133A | 2.22e-04 | 191 | 243 | 9 | 3861_UP | |
| Drug | lacosamide | 2.29e-04 | 52 | 243 | 5 | CID000219078 | |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A | 2.31e-04 | 192 | 243 | 9 | 6990_DN | |
| Drug | Bisacodyl [603-50-9]; Down 200; 11uM; PC3; HT_HG-U133A | 2.40e-04 | 193 | 243 | 9 | 4616_DN | |
| Disease | Malignant neoplasm of prostate | HSP90B1 ABCC4 DCAF6 ADAM9 AZGP1 ASH1L ETV4 PIK3CB NECTIN2 HRAS KMT2A MME DNASE1L2 GOLGA4 VEGFA KRAS RB1 NR3C1 TGFBR2 KMT2D CHEK2 | 3.48e-08 | 616 | 238 | 21 | C0376358 |
| Disease | Prostatic Neoplasms | HSP90B1 ABCC4 DCAF6 ADAM9 AZGP1 ASH1L ETV4 PIK3CB NECTIN2 HRAS KMT2A MME DNASE1L2 GOLGA4 VEGFA KRAS RB1 NR3C1 TGFBR2 KMT2D CHEK2 | 3.48e-08 | 616 | 238 | 21 | C0033578 |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 2.43e-07 | 108 | 238 | 9 | DOID:684 (biomarker_via_orthology) | |
| Disease | Verrucous epidermal nevus | 5.18e-07 | 3 | 238 | 3 | C0362030 | |
| Disease | Nevus Sebaceus of Jadassohn | 5.18e-07 | 3 | 238 | 3 | C4552097 | |
| Disease | Linear nevus sebaceous syndrome | 5.18e-07 | 3 | 238 | 3 | cv:C4552097 | |
| Disease | Nevus sebaceous | 5.18e-07 | 3 | 238 | 3 | C3854181 | |
| Disease | Inflammatory linear verrucous epidermal nevus | 5.18e-07 | 3 | 238 | 3 | C0473574 | |
| Disease | SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME | 5.18e-07 | 3 | 238 | 3 | 163200 | |
| Disease | linear nevus sebaceous syndrome (is_implicated_in) | 5.18e-07 | 3 | 238 | 3 | DOID:0111530 (is_implicated_in) | |
| Disease | Linear Verrucous Epidermal Nevus | 5.18e-07 | 3 | 238 | 3 | C3179502 | |
| Disease | cervical cancer (implicated_via_orthology) | 5.18e-07 | 3 | 238 | 3 | DOID:4362 (implicated_via_orthology) | |
| Disease | Organoid Nevus Phakomatosis | 5.18e-07 | 3 | 238 | 3 | C0265329 | |
| Disease | Noonan syndrome 3 (implicated_via_orthology) | 5.18e-07 | 3 | 238 | 3 | DOID:0060581 (implicated_via_orthology) | |
| Disease | Intellectual Disability | SETD1A ASH1L CIC KCNQ5 SACS SCN8A TRAPPC4 DYNC1H1 PMM2 NAA15 TTI2 NSD1 NBEA CCNA2 AP4E1 AASS | 8.29e-07 | 447 | 238 | 16 | C3714756 |
| Disease | Neoplasm Metastasis | ABCC4 ETV4 CIC STAT1 PIK3C2B NECTIN2 DMD VEGFA KRAS RB1 TGFBR2 | 1.69e-06 | 217 | 238 | 11 | C0027627 |
| Disease | Profound Mental Retardation | 2.05e-06 | 139 | 238 | 9 | C0020796 | |
| Disease | Mental deficiency | 2.05e-06 | 139 | 238 | 9 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 2.05e-06 | 139 | 238 | 9 | C0025363 | |
| Disease | Kabuki make-up syndrome | 2.06e-06 | 4 | 238 | 3 | C0796004 | |
| Disease | BLADDER CANCER | 2.06e-06 | 4 | 238 | 3 | 109800 | |
| Disease | Malignant tumor of urinary bladder | 2.06e-06 | 4 | 238 | 3 | cv:C0005684 | |
| Disease | NEVUS, EPIDERMAL (disorder) | 5.12e-06 | 5 | 238 | 3 | C0334082 | |
| Disease | Follicular thyroid carcinoma | 5.12e-06 | 5 | 238 | 3 | C0206682 | |
| Disease | heart conduction disease (implicated_via_orthology) | 5.52e-06 | 32 | 238 | 5 | DOID:10273 (implicated_via_orthology) | |
| Disease | prostate cancer (implicated_via_orthology) | 6.46e-06 | 33 | 238 | 5 | DOID:10283 (implicated_via_orthology) | |
| Disease | Eye Abnormalities | 9.04e-06 | 17 | 238 | 4 | C0015393 | |
| Disease | Hemimegalencephaly | 1.02e-05 | 6 | 238 | 3 | C0431391 | |
| Disease | Hemangiosarcoma | 1.16e-05 | 18 | 238 | 4 | C0018923 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 1.45e-05 | 19 | 238 | 4 | C3501846 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 1.45e-05 | 19 | 238 | 4 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 1.45e-05 | 19 | 238 | 4 | C1275081 | |
| Disease | Costello syndrome (disorder) | 1.45e-05 | 19 | 238 | 4 | C0587248 | |
| Disease | leukemia (implicated_via_orthology) | 1.45e-05 | 19 | 238 | 4 | DOID:1240 (implicated_via_orthology) | |
| Disease | embryonal carcinoma (is_marker_for) | 1.77e-05 | 7 | 238 | 3 | DOID:3308 (is_marker_for) | |
| Disease | Lymphopenia | 1.77e-05 | 7 | 238 | 3 | C0024312 | |
| Disease | Colorectal Carcinoma | ABCC4 ABCA1 ABCA13 KCNQ5 SACS KDR NR3C2 DMD PMM2 ATG5 KRAS NRAS TGFBR2 TIAM1 GUCY2C ABCE1 CHEK2 EDRF1 | 1.80e-05 | 702 | 238 | 18 | C0009402 |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 1.94e-05 | 41 | 238 | 5 | C0496956 | |
| Disease | Breast adenocarcinoma | 1.94e-05 | 41 | 238 | 5 | C0858252 | |
| Disease | LEOPARD Syndrome | 2.69e-05 | 22 | 238 | 4 | C0175704 | |
| Disease | high grade glioma (implicated_via_orthology) | 2.75e-05 | 44 | 238 | 5 | DOID:3070 (implicated_via_orthology) | |
| Disease | urinary bladder cancer (is_implicated_in) | 3.53e-05 | 76 | 238 | 6 | DOID:11054 (is_implicated_in) | |
| Disease | Neoplasm of the genitourinary tract | 3.86e-05 | 24 | 238 | 4 | cv:C0042065 | |
| Disease | glioblastoma (is_implicated_in) | 3.86e-05 | 24 | 238 | 4 | DOID:3068 (is_implicated_in) | |
| Disease | Noonan Syndrome | 3.86e-05 | 24 | 238 | 4 | C0028326 | |
| Disease | RASopathy (implicated_via_orthology) | 4.20e-05 | 9 | 238 | 3 | DOID:0080690 (implicated_via_orthology) | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 4.67e-05 | 49 | 238 | 5 | DOID:0060037 (implicated_via_orthology) | |
| Disease | long QT syndrome (implicated_via_orthology) | 5.96e-05 | 10 | 238 | 3 | DOID:2843 (implicated_via_orthology) | |
| Disease | thyroid gland papillary carcinoma (is_implicated_in) | 5.96e-05 | 10 | 238 | 3 | DOID:3969 (is_implicated_in) | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 5.96e-05 | 10 | 238 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 5.96e-05 | 10 | 238 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 6.48e-05 | 2 | 238 | 2 | 614470 | |
| Disease | Growth Deficiency and Mental Retardation with Facial Dysmorphism | 6.48e-05 | 2 | 238 | 2 | C1854630 | |
| Disease | MELANOCYTIC NEVUS SYNDROME, CONGENITAL | 6.48e-05 | 2 | 238 | 2 | 137550 | |
| Disease | Melanocytic nevus | 6.48e-05 | 2 | 238 | 2 | cv:C0027962 | |
| Disease | Large congenital melanocytic nevus | 6.48e-05 | 2 | 238 | 2 | cv:C1842036 | |
| Disease | neurodevelopmental disorder with speech impairment and dysmorphic facies (implicated_via_orthology) | 6.48e-05 | 2 | 238 | 2 | DOID:0070417 (implicated_via_orthology) | |
| Disease | Autoimmune lymphoproliferative syndrome type 4 | 6.48e-05 | 2 | 238 | 2 | cv:C2674723 | |
| Disease | autoimmune lymphoproliferative syndrome type 4 (is_implicated_in) | 6.48e-05 | 2 | 238 | 2 | DOID:0110117 (is_implicated_in) | |
| Disease | erythema nodosum (is_marker_for) | 6.48e-05 | 2 | 238 | 2 | DOID:0080750 (is_marker_for) | |
| Disease | boutonneuse fever (is_marker_for) | 6.48e-05 | 2 | 238 | 2 | DOID:14095 (is_marker_for) | |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 6.48e-05 | 2 | 238 | 2 | C2674723 | |
| Disease | retinal telangiectasia (is_marker_for) | 6.48e-05 | 2 | 238 | 2 | DOID:7736 (is_marker_for) | |
| Disease | anterior uveitis (is_marker_for) | 6.48e-05 | 2 | 238 | 2 | DOID:1407 (is_marker_for) | |
| Disease | large congenital melanocytic nevus (is_implicated_in) | 6.48e-05 | 2 | 238 | 2 | DOID:0111359 (is_implicated_in) | |
| Disease | conjunctivitis (is_marker_for) | 6.48e-05 | 2 | 238 | 2 | DOID:6195 (is_marker_for) | |
| Disease | decubitus ulcer (is_marker_for) | 6.48e-05 | 2 | 238 | 2 | DOID:8717 (is_marker_for) | |
| Disease | retinal degeneration (biomarker_via_orthology) | 7.26e-05 | 28 | 238 | 4 | DOID:8466 (biomarker_via_orthology) | |
| Disease | Noonan Syndrome 1 | 8.15e-05 | 11 | 238 | 3 | C4551602 | |
| Disease | Turner Syndrome, Male | 8.15e-05 | 11 | 238 | 3 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 8.15e-05 | 11 | 238 | 3 | C1527404 | |
| Disease | kidney cancer (implicated_via_orthology) | 8.15e-05 | 11 | 238 | 3 | DOID:263 (implicated_via_orthology) | |
| Disease | Colorectal Neoplasms | 9.20e-05 | 277 | 238 | 10 | C0009404 | |
| Disease | Alzheimer's disease (is_implicated_in) | 1.02e-04 | 132 | 238 | 7 | DOID:10652 (is_implicated_in) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.08e-04 | 12 | 238 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | dystonia (implicated_via_orthology) | 1.08e-04 | 12 | 238 | 3 | DOID:543 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 1.10e-04 | 93 | 238 | 6 | C1535926 | |
| Disease | Schizophrenia | SETD1A ABCA1 ABCA13 CMYA5 PIK3CB PLCB1 SYN1 SYN2 KMT2A KCNQ3 KDR TBP ANK3 NR3C1 CCNA2 VPS35 SEPTIN11 ATF4 GABBR1 | 1.11e-04 | 883 | 238 | 19 | C0036341 |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 1.40e-04 | 13 | 238 | 3 | DOID:0112202 (implicated_via_orthology) | |
| Disease | hearing impairment | 1.47e-04 | 98 | 238 | 6 | C1384666 | |
| Disease | Bladder Neoplasm | 1.47e-04 | 140 | 238 | 7 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.54e-04 | 141 | 238 | 7 | C0005684 | |
| Disease | carcinoma (implicated_via_orthology) | 1.69e-04 | 64 | 238 | 5 | DOID:305 (implicated_via_orthology) | |
| Disease | Postherpetic neuralgia | 1.93e-04 | 3 | 238 | 2 | C0032768 | |
| Disease | complement C3D fragment measurement | 1.93e-04 | 3 | 238 | 2 | EFO_0020277 | |
| Disease | Primary Erythermalgia | 1.93e-04 | 3 | 238 | 2 | C0014805 | |
| Disease | allergic contact dermatitis (is_marker_for) | 1.93e-04 | 3 | 238 | 2 | DOID:3042 (is_marker_for) | |
| Disease | arteriovenous malformations of the brain (is_marker_for) | 1.93e-04 | 3 | 238 | 2 | DOID:0060688 (is_marker_for) | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 1.93e-04 | 3 | 238 | 2 | C1833661 | |
| Disease | Bone osteosarcoma | 1.93e-04 | 3 | 238 | 2 | cv:C0585442 | |
| Disease | B Virus Infection | 1.93e-04 | 3 | 238 | 2 | C0037140 | |
| Disease | Herpesviridae Infections | 1.93e-04 | 3 | 238 | 2 | C0019372 | |
| Disease | vulva squamous cell carcinoma (is_marker_for) | 1.93e-04 | 3 | 238 | 2 | DOID:2101 (is_marker_for) | |
| Disease | OSTEOGENIC SARCOMA | 1.93e-04 | 3 | 238 | 2 | 259500 | |
| Disease | GIANT PIGMENTED HAIRY NEVUS | 1.93e-04 | 3 | 238 | 2 | C1842036 | |
| Disease | membranous glomerulonephritis (is_implicated_in) | 1.93e-04 | 3 | 238 | 2 | DOID:10976 (is_implicated_in) | |
| Disease | Neoplasms, Experimental | 1.96e-04 | 66 | 238 | 5 | C0027659 | |
| Disease | breast carcinoma (is_marker_for) | 1.96e-04 | 66 | 238 | 5 | DOID:3459 (is_marker_for) | |
| Disease | RASopathy | 2.19e-04 | 15 | 238 | 3 | cv:C5555857 | |
| Disease | congenital heart disease (implicated_via_orthology) | 2.42e-04 | 69 | 238 | 5 | DOID:1682 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ESADKLLYTDRYPEE | 561 | Q15361 | |
| DPSYVDVTYDFIIKR | 216 | P30926 | |
| YYAIEVDPVLTVEEK | 131 | Q9H0P0 | |
| PVIYYVPDFISKEEE | 21 | Q3KRA9 | |
| KDYSEDEIYRFNSPL | 961 | Q6ZRH7 | |
| TYAEIEKRYPEEFAL | 336 | O60825 | |
| ADYYEKISDPLDLIT | 2481 | Q9NR48 | |
| LVKVTELVDAVYDPY | 341 | P83436 | |
| ILYEEPLQEEDKYAS | 2001 | Q68DQ2 | |
| VDITEGDRKPDYTAY | 186 | P18848 | |
| KDVVTSYLQVEEYEP | 86 | Q8N7M0 | |
| KVAPYFERSIVDLYT | 316 | Q86YB8 | |
| YVLPYEAAKEGAFVE | 1206 | O95477 | |
| LVRKTDAVYDPAEYD | 271 | Q9UDR5 | |
| KVPQVEVYFFVELYE | 5456 | Q8WXG9 | |
| PEEYLSSIYEEIEGK | 811 | Q9Y6D5 | |
| ELYPYIVEFEEEAKN | 106 | Q7Z2E3 | |
| EIYAPKLQEFAYVTD | 201 | O96020 | |
| SFEVIVEPTEKFYYI | 231 | P01024 | |
| INIIKFYEVYCDVEP | 3301 | Q96DT5 | |
| PKDVVDAVIDVYYVL | 1736 | Q86UQ4 | |
| EIEAEYAALDKREPY | 211 | Q9P2G1 | |
| YIYLFDPKDDTAREL | 276 | Q58WW2 | |
| AEEEYLERDFEYKTP | 1176 | P11532 | |
| CFQVEIPKIDVYLYE | 36 | Q9H9G7 | |
| TLYQDEITEREAEPY | 21 | Q9H1Y0 | |
| VDDQSVYPKALRDEY | 206 | O96017 | |
| EYPGNELLLVYDKDF | 96 | Q8IWG1 | |
| QYYPREFSEEEKETL | 256 | Q8IWG1 | |
| YSYLLDKETPEEVIA | 521 | Q9UPM8 | |
| VAGERYVYKFVCEPE | 411 | P43268 | |
| LPEVENLSKRYEEIY | 311 | P06400 | |
| EYDPTIEDSYRKQVV | 31 | P01112 | |
| EYDPTIEDSYRKQVV | 31 | P01116 | |
| KIFVPDYDPTIEDSY | 36 | O14807 | |
| EYDPTIEDSYRKQVV | 31 | P01111 | |
| EEAIALAEKYGIPYF | 146 | P51159 | |
| GIFVEKYDPTIEDSY | 26 | P62834 | |
| GIFVEKYDPTIEDSY | 26 | P61224 | |
| YGPVIECDIVKDYAF | 101 | Q9BWF3 | |
| LLEYTEEYDQIFAPK | 1281 | Q96L73 | |
| EENFYLEPYLKEVIR | 86 | P14927 | |
| IYYADVKEPESFPFV | 106 | P51151 | |
| PQVETKIDVSYEYRF | 26 | Q14699 | |
| EPELYEEVTIYFSDI | 816 | P25092 | |
| RKTLQIDGPYDEAFY | 356 | Q9H8X2 | |
| DLVLPEYVVEFEYIT | 611 | Q6ZRR7 | |
| KNPREDYLDVYVFGV | 416 | P00751 | |
| EAGIPEFYDYDVALI | 566 | P00751 | |
| KDEAFYHPRLIIYEE | 176 | Q6ZW49 | |
| GVLPVKTFLEYLEYE | 706 | Q9H2M9 | |
| EIRYPEDLEFVYETV | 601 | O94952 | |
| YVRAQFEYDPAKDDL | 616 | O14936 | |
| EDFVPYKGDLLEVEY | 141 | Q8WUE5 | |
| FTAEFYQRYKEELVP | 476 | O00370 | |
| LVSEFPYIEAEVKYG | 526 | P43304 | |
| PEKILIYELYSEDLS | 406 | Q9HBG6 | |
| VLENIEPEIVYAGYD | 741 | P08235 | |
| SVIKNYEDYFPEIFR | 251 | P43364 | |
| KEYTDVYPEIIERAG | 311 | Q9UNF1 | |
| AILKEVESPYDVHDY | 926 | O75420 | |
| PEEYYESLSELRQKG | 316 | Q8N9B5 | |
| HVTVDLKYYRPTEVD | 316 | O60547 | |
| PRYEELAESVEEYVL | 316 | Q8N201 | |
| VERSQLDISDPYKVY | 111 | Q15306 | |
| REFSPEEGLYYNKAI | 926 | Q3B7T1 | |
| EPTEFEYLRKVLFEY | 2171 | Q13439 | |
| VKAINFLPVDYEIEY | 51 | Q9UBS5 | |
| FLPVDYEIEYVCRGE | 56 | Q9UBS5 | |
| YEELDLPAVFLQYEE | 371 | P14324 | |
| LYYEPAELKLFENIE | 311 | P46020 | |
| EEIYEYIIFRGSDIK | 61 | Q9BX40 | |
| LYSEDELPAEFKLYL | 171 | Q9Y6A4 | |
| LDFFEKPDYEYLRTL | 296 | Q9HCP0 | |
| ETLRPYDVKDVIEQY | 536 | O43525 | |
| LRPYDVKDVIEQYSA | 541 | Q9NR82 | |
| ETLRPYDVKDVIEQY | 551 | P56696 | |
| EESYPYFLIVADEGL | 136 | Q8IY21 | |
| IDTYQEFEETYIPKD | 51 | P0DML3 | |
| PIEDFRELIKYLEEY | 1041 | Q63HM2 | |
| ESEVNHYYEPKLIID | 461 | Q16659 | |
| LLIPDDFKDYTLLYE | 96 | Q719H9 | |
| KPEAVQYYEDGARIE | 191 | Q96HS1 | |
| AVFCEPVVKLYYREE | 116 | Q6L8Q7 | |
| PVVKLYYREEAVAED | 121 | Q6L8Q7 | |
| PDGREIVFYKVIDYV | 306 | P35913 | |
| ELTYEEIRDTYPEEY | 331 | Q16875 | |
| IIPYLEAHDYEKSED | 256 | Q6NT32 | |
| AIDEDSPREKIYYVF | 1301 | Q5H8C1 | |
| EEDVVVYAPEYLTKL | 341 | P08473 | |
| PNVIEYYENFLEDKA | 61 | Q86SG6 | |
| PYFREYFLSEIDEAK | 56 | O60662 | |
| PEKAASLEYDYETIR | 286 | Q96N66 | |
| IVDKFVIVDCRYPYE | 431 | P30305 | |
| EDLPLYKEKLEVYFS | 106 | Q7L5L3 | |
| LEVIEPEVLYAGYDS | 536 | P04150 | |
| RKTSDEVYDEDPFAY | 1131 | A8MYU2 | |
| LRGEELTYDYKFPIE | 2681 | Q9UMN6 | |
| YGPVIECDIVKDYAF | 101 | Q9BQ04 | |
| PEELYQRKIESEEYE | 526 | A2RRP1 | |
| YYEGRFPCLEEKVLE | 651 | Q9H0A0 | |
| SPDKVDYEYSELLLY | 181 | Q9BXJ9 | |
| IKSIRVDVYYLDDPV | 121 | Q7Z553 | |
| DFYEKLAASIAPEIY | 331 | P33993 | |
| YPELVLDKALDYEER | 191 | Q9Y5F1 | |
| GIPELSDLEDLKYVY | 1286 | O00750 | |
| SDLEDLKYVYDALRP | 1291 | O00750 | |
| YPELVLDKALDYEEL | 191 | Q9Y5F2 | |
| VLDSGRLKEYDEPYV | 1246 | O15439 | |
| NISPDDKYIYVADIL | 226 | Q15165 | |
| LKFSYRENLEDEYEP | 81 | P49643 | |
| YLEDGFAYVPLKDIV | 201 | P49643 | |
| KGYEVIYLTEPVDEY | 561 | P14625 | |
| DDPEYRKFLESYATD | 156 | Q9BZI7 | |
| IEDLIKYLDPEYIDR | 61 | O75935 | |
| DKLTEFLQDPDRYYD | 191 | Q99999 | |
| DVYLIDEPSAYLDSE | 481 | P61221 | |
| KIEFYISESLPEYFA | 71 | O60308 | |
| EGVTALPYFLIKYDE | 191 | O95352 | |
| RKDAVSVVDTYLYPD | 106 | Q92874 | |
| YIQVTYVTPFFEEKE | 1946 | Q96BY6 | |
| EDVEDPVYQYIVFEA | 191 | O75553 | |
| LKEVESPYEVHDYIR | 1161 | Q6Y7W6 | |
| DKYIEYDPVIILINA | 66 | Q9H2C2 | |
| DLLKEDPVAFEYLYL | 271 | Q5SYB0 | |
| IPSEEDYFEKYTLID | 3046 | Q8N3K9 | |
| LASKYEEIYPPEVDE | 296 | P78396 | |
| EEIYPPEVDEFVYIT | 301 | P78396 | |
| DETLETEKAQYYLPD | 231 | P61163 | |
| DLLPEDFVVYTYNKE | 86 | Q13443 | |
| IFPDNYDAEEREKTY | 246 | Q8NDY3 | |
| DIEVLEGKPIYVDCY | 1356 | Q12955 | |
| ETFFELDYPKYEVLL | 71 | Q16739 | |
| IPLFLESIDEDDDYY | 206 | Q9BRF8 | |
| EDNIYEDIIYPTKEN | 306 | Q68D51 | |
| IDKSYREDVYDLFPG | 1016 | Q6MZM0 | |
| DYVAKYPVIQTDDER | 441 | Q8N4S9 | |
| KEAFVRSLVYTPDYD | 571 | Q16798 | |
| YIPVDQEELRDYVKA | 2881 | Q14204 | |
| EDSVPEDKTERYVLY | 66 | P52803 | |
| SDIYLKFYEPQDRDD | 266 | Q92636 | |
| RGEELTYDYKFPIED | 3936 | Q03164 | |
| INESEPIVVYDKEYL | 361 | P42892 | |
| LDKVFNDYTAVPDLY | 516 | P42892 | |
| ESQIEREEKYPYFIN | 1171 | Q8NDH2 | |
| KFEEIYPPEVAEFVY | 266 | P20248 | |
| QPLDREEKDAYVFYA | 296 | Q12864 | |
| IDTYQEFEETYIPKD | 51 | P0DML2 | |
| VKLELEFYADYSDNP | 866 | P51530 | |
| RIQEEYEKLGDISYP | 361 | Q9UKG4 | |
| VVINLEYESDFKPYL | 3811 | Q9NZJ4 | |
| TQYPDVYAREEVALK | 61 | O43186 | |
| FDALISKIYPSRDEY | 106 | Q99496 | |
| LKYADDPEVLFYLDD | 851 | A6NMZ7 | |
| LIKEFVIIDCRYPYE | 376 | P30304 | |
| NLRITYDFPKEYFEE | 396 | Q5VU65 | |
| YDFPKEYFEEQLTTV | 401 | Q5VU65 | |
| TLPKESYIQEDDIYD | 2036 | Q12923 | |
| RTPDELYFEEGDIIY | 26 | Q92882 | |
| EVYIPQFKLEEHYEL | 306 | P05120 | |
| VEKYDYVFPENGLVA | 61 | O15305 | |
| EDVYKFEDLLSPAEY | 211 | Q9GZS1 | |
| STVYIPEAEYKIEED | 1886 | P0C091 | |
| LYFYRDPEEIEKEEQ | 201 | P08865 | |
| AEAYKYIDITRPEEV | 191 | Q16799 | |
| KLLEYFVEEYFDQNP | 86 | Q6P1K8 | |
| YATAEPFIDAKYDVR | 301 | P17600 | |
| YATAEPFIDSKYDIR | 301 | Q92777 | |
| EEYLERDFEYKSPEE | 1146 | P46939 | |
| PEKFVYEDVAIAAYL | 326 | Q8IYL2 | |
| ALETEDPALIYDYAI | 721 | Q68CR1 | |
| IYQLDSYAPRAEAEK | 16 | Q9Y296 | |
| EELEQKYTYEHDPIT | 281 | P42224 | |
| DDSYKPIVEYIDAQF | 111 | Q9NVA2 | |
| EEYESGYAFLPDLLI | 341 | Q9UPR3 | |
| YIFEVEGKPHSVEEY | 311 | Q8NDG6 | |
| YYDLVESTFEKLRLP | 376 | P04053 | |
| PYCYTIDVEIKLDEE | 561 | Q14CZ7 | |
| RDTSDVKELIPEFYY | 2426 | Q8NFP9 | |
| EDLDPYYADKKTFIV | 76 | Q15858 | |
| YTYRILPNEDDKFTV | 51 | Q92835 | |
| FYVETVVTYKEDFVP | 61 | A0A096LP01 | |
| VKYVLDDFESPQAVY | 261 | O15466 | |
| FETVAVKIFPYEEYA | 271 | P37173 | |
| NEEITYDYKFPIEDV | 1936 | Q9UPS6 | |
| LYKLESDYEILERFP | 266 | P41252 | |
| PDYEEYINLEGTRKA | 301 | Q13017 | |
| IPYTEEFSEKLEAEY | 356 | Q9Y6Y8 | |
| GKEDEVSPYDYVLQV | 236 | P42338 | |
| EIQRVFEGPYKEYHE | 336 | Q9C0C4 | |
| KVLVDPESGRYYFVE | 881 | E7EW31 | |
| YYLVAPELEVEEFNA | 211 | Q15120 | |
| TVELYEDRKEGYPAV | 256 | Q15120 | |
| SVADTIEEKFVPYYD | 526 | O60518 | |
| VDEEITYDYKFPLED | 1676 | O15047 | |
| AFEPYLEILEVYSTK | 11 | O95470 | |
| EEEAEHPIKISYAQY | 546 | Q08188 | |
| AYPEEAYIADLDAKS | 246 | P53396 | |
| YDYLVDFLDLSFPKE | 386 | Q9Y471 | |
| AEDVLGELEYDKVPY | 1446 | Q96RK0 | |
| VVDEDHELIYCYVPK | 111 | Q9NPF2 | |
| VEPLEKITDAYLDQY | 911 | Q6P2Q9 | |
| IAFYRKEYVEPELHI | 376 | Q7KZ85 | |
| GIFVEKYDPTIEDSY | 26 | A6NIZ1 | |
| KYDPTIEDSYREQVE | 31 | A6NIZ1 | |
| LKYEFDIEFDIPITY | 76 | Q9Y3C8 | |
| GPFVYYVKSTLLEED | 116 | Q9UM82 | |
| DAIKPFLDYYDLVDG | 181 | O14656 | |
| EDIYELLYKEIEICP | 826 | Q13009 | |
| LTLYRDEAPYKEEEV | 1706 | O75970 | |
| YFPEIIERASYTLEK | 481 | Q12816 | |
| YLEVYDGPEEEARLK | 391 | Q6NXR4 | |
| KLLEYFVEEYFDQNP | 86 | Q13888 | |
| VLYYVEKELAQFDPA | 311 | Q71H61 | |
| DLPEKIEYVFTVIYT | 151 | Q9Y5Y9 | |
| KVRAEIYEAFENIYP | 316 | P20226 | |
| CYPDRVDYVDKVLET | 361 | Q96QK1 | |
| FSLQPEEEEKYTVIY | 216 | A1X283 | |
| SEFFVYKYEIPLVLE | 146 | Q5SVQ8 | |
| EAYRTVEELYKRPDE | 406 | Q8IZM8 | |
| EEFYTKAESLIGVYP | 1191 | Q14683 | |
| LEDFDPYYLTQKTFV | 81 | Q9UQD0 | |
| INKDESYRPIVDYID | 111 | Q92599 | |
| AIYDKYKEFAIPEEE | 186 | Q13084 | |
| YLEDDIRPDIKDDIY | 41 | O00767 | |
| FYPPAYEESLEVEKQ | 96 | Q8N6L7 | |
| ILEPEKALEVYDEAY | 741 | Q8NDW8 | |
| YVPYEAKEEFLDLLD | 86 | Q9BQ65 | |
| IYAYHVEREKERDPE | 31 | Q8N0U8 | |
| KDYVPDTYADVIEAL | 796 | Q9NQ66 | |
| KFVVYEVLREDEFSP | 391 | Q16222 | |
| GIYTCFLEYKPTVEE | 136 | Q9BS86 | |
| TPLLSLKDFYDIYEV | 391 | Q9ULQ1 | |
| EPVYVQRAKAYLEEE | 171 | P25311 | |
| PALEEDVIYHVKYDD | 176 | Q96T88 | |
| PSAVAVVDEYFKEKY | 861 | P86452 | |
| DFGLARDIYKDPDYV | 1046 | P35968 | |
| FYKLDEDIIPELRFY | 1016 | Q5SVZ6 | |
| IFQEYPDEIEYIFKP | 61 | P15692 | |
| ETVIILEDYADPYDA | 196 | Q5VZ18 | |
| EYYEALPELKLVIDQ | 731 | P06737 | |
| VYEIKYPLISDFGEE | 71 | A7MCY6 | |
| LERETFKYPNFDVEY | 311 | Q69YN4 | |
| YEYEDEAKLVIFPDH | 131 | Q92995 | |
| VSDTYDPYLDVALEI | 261 | Q9P275 | |
| PKEVLGNYEILYDEE | 371 | O95922 | |
| SEIYEAFENIYPILK | 356 | Q6SJ96 | |
| IIDAIKPFLDYYEQV | 186 | O14657 | |
| AKIIRYEDYSPGFEI | 426 | Q7Z402 | |
| TAYVYRVPEEAKILF | 321 | Q9BZW5 | |
| RIPKGEELTYDYQFD | 5501 | O14686 | |
| LDLYPEYAHKFVEDI | 651 | Q96L42 | |
| EIPEDYYIVANAELT | 206 | Q8N8K9 | |
| ETEEEYEKLPAYLAT | 91 | Q92539 | |
| GYPAKEYTFRLDVEE | 261 | Q9Y3Q0 | |
| EVRAKPYTLEEFSYD | 1706 | Q13402 | |
| EEEEYLDKINPIYDA | 501 | Q92692 |